<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jats-oasis2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">mBio</journal-id><journal-id journal-id-type="iso-abbrev">mBio</journal-id><journal-id journal-id-type="publisher-id">mbio</journal-id><journal-title-group><journal-title>mBio</journal-title></journal-title-group><issn pub-type="epub">2150-7511</issn><publisher><publisher-name>American Society for Microbiology</publisher-name><publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">9600172</article-id><article-id pub-id-type="pmid">36040031</article-id><article-id pub-id-type="publisher-id">01789-22</article-id><article-id pub-id-type="doi">10.1128/mbio.01789-22</article-id><article-id pub-id-type="publisher-id">mbio.01789-22</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="biological-terms"><compound-subject><compound-subject-part content-type="code">environmental-microbiology</compound-subject-part><compound-subject-part content-type="label">Environmental Microbiology</compound-subject-part></compound-subject></subj-group></article-categories><title-group><article-title><italic toggle="yes">N</italic>-Succinyltransferase Encoded by a Cryptic Siderophore Biosynthesis Gene Cluster in <italic toggle="yes">Streptomyces</italic> Modifies Structurally Distinct Antibiotics</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Schneider</surname><given-names>Olha</given-names></name><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><!--<xref ref-type="other" rid="cr1 cr2 cr3"/>--></contrib><contrib contrib-type="author"><name><surname>Zehl</surname><given-names>Martin</given-names></name><xref rid="aff2" ref-type="aff">
<sup>b</sup>
</xref><!--<xref ref-type="other" rid="cr4 cr5 cr6"/>--></contrib><contrib contrib-type="author"><name><surname>Ueoka</surname><given-names>Reiko</given-names></name><xref rid="aff3" ref-type="aff">
<sup>c</sup>
</xref><!--<xref ref-type="other" rid="cr7 cr8"/>--></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9722-4435</contrib-id><name><surname>R&#x000fc;ckert</surname><given-names>Christian</given-names></name><xref rid="aff4" ref-type="aff">
<sup>d</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Buche</surname><given-names>Tobias</given-names></name><xref rid="aff4" ref-type="aff">
<sup>d</sup>
</xref><!--<xref ref-type="other" rid="cr9 cr10"/>--></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1847-252X</contrib-id><name><surname>Jiang</surname><given-names>Yi</given-names></name><xref rid="aff5" ref-type="aff">
<sup>e</sup>
</xref><!--<xref ref-type="other" rid="cr11 cr12"/>--></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Qin-Yuan</given-names></name><xref rid="aff5" ref-type="aff">
<sup>e</sup>
</xref><xref rid="aff6" ref-type="aff">
<sup>f</sup>
</xref><!--<xref ref-type="other" rid="cr13 cr14"/>--></contrib><contrib contrib-type="author"><name><surname>Piel</surname><given-names>J&#x000f6;rn</given-names></name><xref rid="aff3" ref-type="aff">
<sup>c</sup>
</xref><!--<xref ref-type="other" rid="cr15"/>--></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9324-245X</contrib-id><name><surname>Zotchev</surname><given-names>Sergey B.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><email>sergey.zotchev@univie.ac.at</email><!--<xref ref-type="other" rid="cr16 cr17 cr18 cr19"/>--></contrib><aff id="aff1">
<label>a</label>
<addr-line>Department of Pharmaceutical Sciences, Division of Pharmacognosy, <institution-wrap><institution>University of Vienna</institution><institution-id institution-id-type="grid">grid.10420.37</institution-id></institution-wrap>, Vienna, Austria</addr-line>
</aff><aff id="aff2">
<label>b</label>
<addr-line>Department of Analytical Chemistry, Faculty of Chemistry, <institution-wrap><institution>University of Vienna</institution><institution-id institution-id-type="grid">grid.10420.37</institution-id></institution-wrap>, Vienna, Austria</addr-line>
</aff><aff id="aff3">
<label>c</label>
<addr-line>Department of Biology, Eidgen&#x000f6;ssische Technische Hochschule (ETH) Zurich, Zurich, Switzerland</addr-line>
</aff><aff id="aff4">
<label>d</label>
<addr-line>Center for Biotechnology, <institution-wrap><institution>Bielefeld University</institution><institution-id institution-id-type="grid">grid.7491.b</institution-id></institution-wrap>, Bielefeld, Germany</addr-line>
</aff><aff id="aff5">
<label>e</label>
<addr-line>Yunnan Institute of Microbiology, Yunnan University, Kunming, People&#x02019;s Republic of China</addr-line>
</aff><aff id="aff6">
<label>f</label>
<addr-line>Life Sciences Lab Center, School of Life Sciences, Yunnan University, Kunming, People&#x02019;s Republic of China</addr-line>
</aff></contrib-group><contrib-group><contrib contrib-type="editor"><role>Editor</role><name><surname>Ausubel</surname><given-names>Frederick M.</given-names></name><aff>Mass General Hospital</aff></contrib></contrib-group><author-notes><fn fn-type="COI-statement"><p>The authors declare no conflict of interest.</p></fn></author-notes><pub-date publication-format="electronic" date-type="pub"><day>30</day><month>8</month><year>2022</year></pub-date><pub-date publication-format="electronic" date-type="collection"><season>Sep-Oct</season><year>2022</year></pub-date><pub-date pub-type="pmc-release"><day>30</day><month>8</month><year>2022</year></pub-date><!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.--><volume>13</volume><issue>5</issue><elocation-id>e01789-22</elocation-id><history>
<date date-type="received"><day>21</day><month>7</month><year>2022</year></date>
<date date-type="accepted"><day>10</day><month>8</month><year>2022</year></date>
</history><permissions><copyright-statement>Copyright &#x000a9; 2022 Schneider et al.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Schneider et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2022-08-30"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="mbio.01789-22.pdf"/><abstract><title>ABSTRACT</title><p>The antibiotic desertomycin A and its previously undescribed inactive <italic toggle="yes">N</italic>-succinylated analogue, desertomycin X, were isolated from <italic toggle="yes">Streptomyces</italic> sp. strain YIM 121038. Genome sequencing and analysis readily identified the desertomycin biosynthetic gene cluster (BGC), which lacked genes encoding acyltransferases that would account for desertomycin X formation. Scouting the genome for putative <italic toggle="yes">N-</italic>acyltransferase genes led to the identification of a candidate within a cryptic siderophore BGC (<italic toggle="yes">csb</italic>) encoding a putative homologue of the <italic toggle="yes">N</italic>6&#x02032;-hydroxylysine acetyltransferase IucB. Expression of the codon-optimized gene designated <italic toggle="yes">csbC</italic> in <named-content content-type="genus-species">Escherichia coli</named-content> yielded the recombinant protein that was able to <italic toggle="yes">N</italic>-succinylate desertomycin A as well as several other structurally distinct antibiotics harboring amino groups. Some antibiotics were rendered antibiotically inactive due to the CsbC-catalyzed succinylation <italic toggle="yes">in vitro</italic>. Unlike many known <italic toggle="yes">N</italic>-acyltransferases involved in antibiotic resistance, CsbC could not efficiently acetylate the same antibiotics. When expressed in <named-content content-type="genus-species">E. coli</named-content>, CsbC provided low-level resistance to kanamycin and ampicillin, suggesting that it may play a role in antibiotic resistance in natural habitats, where the concentration of antibiotics is usually low.</p></abstract><kwd-group><title>KEYWORDS</title><kwd><italic toggle="yes">Streptomyces</italic></kwd><kwd>desertomycin analogue</kwd><kwd>succinyltransferase</kwd><kwd>antibiotic resistance</kwd><kwd><italic toggle="yes">N</italic>-succinyltransferase</kwd></kwd-group><funding-group specific-use="FundRef"><award-group award-type="grant" id="award1"><funding-source id="GS1">
<institution-wrap><institution>Universit&#x000e4;t Wien (University of Vienna)</institution><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100003065</institution-id></institution-wrap>
</funding-source><principal-award-recipient>
<name><surname>Zotchev</surname><given-names>Sergey B.</given-names></name>
</principal-award-recipient></award-group><award-group award-type="grant" id="award2"><funding-source id="GS2">
<institution-wrap><institution>Universit&#x000e4;t Wien (University of Vienna)</institution><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100003065</institution-id></institution-wrap>
</funding-source><principal-award-recipient>
<name><surname>Schneider</surname><given-names>Olha</given-names></name>
</principal-award-recipient></award-group><award-group award-type="grant" id="award3"><funding-source id="GS3">
<institution-wrap><institution>Universit&#x000e4;t Wien (University of Vienna)</institution><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100003065</institution-id></institution-wrap>
</funding-source><principal-award-recipient>
<name><surname>Zehl</surname><given-names>Martin</given-names></name>
</principal-award-recipient></award-group><award-group award-type="grant" id="award4"><funding-source id="GS4">
<institution-wrap><institution>Eidgen&#x000f6;ssische Technische Hochschule Z&#x000fc;rich (ETH)</institution><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100003006</institution-id></institution-wrap>
</funding-source><principal-award-recipient>
<name><surname>Ueoka</surname><given-names>Reiko</given-names></name>
</principal-award-recipient></award-group><award-group award-type="grant" id="award5"><funding-source id="GS5">
<institution-wrap><institution>Eidgen&#x000f6;ssische Technische Hochschule Z&#x000fc;rich (ETH)</institution><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100003006</institution-id></institution-wrap>
</funding-source><principal-award-recipient>
<name><surname>Piel</surname><given-names>J&#x000f6;rn</given-names></name>
</principal-award-recipient></award-group><award-group award-type="grant" id="award6"><funding-source id="GS6">
<institution-wrap><institution>Yunnan University (YNU)</institution><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100007839</institution-id></institution-wrap>
</funding-source><principal-award-recipient>
<name><surname>Jiang</surname><given-names>Yi</given-names></name>
</principal-award-recipient></award-group><award-group award-type="grant" id="award7"><funding-source id="GS7">
<institution-wrap><institution>Yunnan University (YNU)</institution><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100007839</institution-id></institution-wrap>
</funding-source><principal-award-recipient>
<name><surname>Li</surname><given-names>Qinyuan</given-names></name>
</principal-award-recipient></award-group><award-group award-type="grant" id="award8"><funding-source id="GS8">
<institution-wrap><institution>Austrian Science Fund (FWF)</institution><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100002428</institution-id></institution-wrap>
</funding-source><award-id>P 32823</award-id><principal-award-recipient>
<name><surname>Schneider</surname><given-names>Olha</given-names></name>
</principal-award-recipient></award-group><award-group award-type="grant" id="award9"><funding-source id="GS9">
<institution-wrap><institution>Universit&#x000e4;t Bielefeld (Uni Bielefeld)</institution><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100005721</institution-id></institution-wrap>
</funding-source><principal-award-recipient>
<name><surname>R&#x000fc;ckert</surname><given-names>Christian</given-names></name>
</principal-award-recipient></award-group><award-group award-type="grant" id="award10"><funding-source id="GS10">
<institution-wrap><institution>Universit&#x000e4;t Bielefeld (Uni Bielefeld)</institution><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100005721</institution-id></institution-wrap>
</funding-source><principal-award-recipient>
<name><surname>Busche</surname><given-names>Tobias</given-names></name>
</principal-award-recipient></award-group></funding-group><counts><count count="9" count-type="supplementary-material"/><fig-count count="8"/><table-count count="2"/><equation-count count="0"/><ref-count count="35"/><page-count count="15"/><word-count count="10098"/></counts><custom-meta-group><custom-meta><meta-name>cover-date</meta-name><meta-value>September/October 2022</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p>Antibiotics are secondary metabolites (SMs) produced by certain bacteria and fungi, which are not required for growth, development, or reproduction, but may provide an advantage in competition for nutrients or defense against predators in natural environments. Genes encoding enzymes for the biosynthesis of SMs are usually colocalized in the genome and form so-called &#x0201c;biosynthetic gene clusters&#x0201d; (BGCs). Typical BGCs contain &#x0201c;core&#x0201d; genes responsible for the biosynthesis of a molecular scaffold, accessory genes encoding enzymes for scaffold modification, genes that regulate the BGC&#x02019;s expression, and resistance genes for self-protection against the endogenously produced compound (<xref rid="B1" ref-type="bibr">1</xref>). Actinomycetes, filamentous Gram-positive bacteria of the phylum <italic toggle="yes">Actinobacteria</italic>, produce thousands of SMs, including ca 50% of all clinically used antibiotics (<xref rid="B2" ref-type="bibr">2</xref>). Actinomycetes protect themselves from the toxic effects of endogenously produced antibiotics using a variety of specific mechanisms (<xref rid="B3" ref-type="bibr">3</xref>). For example, the ErmE protein of the erythromycin producer <named-content content-type="genus-species">Saccharopolyspora erythraea</named-content> catalyzes methylation of 23S rRNA, thus preventing binding of erythromycin to the ribosome and inhibiting protein synthesis (<xref rid="B4" ref-type="bibr">4</xref>). The tetracycline producer <named-content content-type="genus-species">Streptomyces rimosus</named-content> encodes, within the tetracycline BGC, a transmembrane protein channel that pumps the antibiotic out of the cells by coupling antibiotic excretion with proton import (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>). Other prevalent examples of resistance mechanisms are the direct enzymatic modification of antibiotics via hydrolysis or transfer of a specific chemical group that prevents an antibiotic from binding to its target. Despite the structural diversity of antibiotics, two modes of the latter modification predominate: <italic toggle="yes">N</italic>-acetylation of amino groups and <italic toggle="yes">O</italic>-phosphorylation of hydroxyl groups, for which the donor cofactors are acyl coenzyme A (acyl-CoA) and ATP, respectively (<xref rid="B6" ref-type="bibr">6</xref>). <italic toggle="yes">N</italic>-Acetylation of amino groups is catalyzed by GNAT enzymes (Gcn5-related <italic toggle="yes">N</italic>-acetyltransferases), most of which use acetyl-CoA as a cosubstrate (<xref rid="B7" ref-type="bibr">7</xref>). However, GNAT proteins exist that prefer different acyl donors, such as myristoyl-CoA in <named-content content-type="genus-species">Saccharomyces cerevisiae</named-content> (<xref rid="B8" ref-type="bibr">8</xref>) or succinyl-CoA in <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> (<xref rid="B9" ref-type="bibr">9</xref>). The latter protein was shown to both acylate and succinylate mycobacterial nucleoid-associated protein HU (<xref rid="B10" ref-type="bibr">10</xref>). The involvement of <italic toggle="yes">N</italic>-acetyltransferases in antibiotic resistance first was shown in the kanamycin producer <named-content content-type="genus-species">Streptomyces kanamyceticus</named-content>, which possesses an aminoglycoside <italic toggle="yes">N</italic>-acetyltransferase (AAC) activity (<xref rid="B11" ref-type="bibr">11</xref>). The <italic toggle="yes">aac</italic> gene (new designation <italic toggle="yes">kanM</italic>) encoding the AAC enzyme has been cloned in <named-content content-type="genus-species">Streptomyces</named-content>
<named-content content-type="genus-species">lividans</named-content>, where it functioned as a resistance determinant against kanamycin (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>). Except for the aforementioned KanM enzyme from <italic toggle="yes">S. kanamyceticus</italic>, not much information is available about the AAC proteins from <italic toggle="yes">Streptomyces.</italic></p><p>Here, we describe the characterization of a GNAT-like protein, CsbC, encoded by a BGC for a cryptic siderophore in the newly isolated strain <italic toggle="yes">Streptomyces</italic> YIM 121038. We demonstrate <italic toggle="yes">N</italic>-succinyltransferase activity of CsbC on a range of structurally distinct antibiotics, some of which completely lose their activity due to such modification. The latter suggests that proteins similar to CsbC may contribute to antibiotic resistance in nature, providing an additional line of defense against competitors capable of antibiotic biosynthesis.</p></sec><sec sec-type="results" id="s2"><title>RESULTS</title><sec id="s2-1"><title>Isolation and genome analyses of <italic toggle="yes">Streptomyces</italic> sp. strain YIM 121038.</title><p>The actinobacterial strain YIM 121038 was isolated from a rain forest soil sample collected in the Province Yunnan, China. Its 16S rRNA gene sequence was deposited in NCBI (accession no. <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=2136401" ext-link-type="uri">NCBI:txid2136401</ext-link>). According to its morphological and physiological properties and the 16S rRNA BLAST results, the YIM 121038 isolate was identified as a strain of <italic toggle="yes">Streptomyces</italic> sp. The 16S rRNA gene sequence similarity between the strain YIM121038 and <named-content content-type="genus-species">Streptomyces spectabilis</named-content> was 98.43%.</p><p>The genome of <italic toggle="yes">Streptomyces</italic> sp. strain YIM 121038 was sequenced and shown to contain one linear chromosome of 10,130,554&#x02009;bp and a linear plasmid of 967,890&#x02009;bp. <italic toggle="yes">In silico</italic> analysis of the draft genome for the presence of biosynthetic gene clusters (BGCs) using antiSMASH 6.0 (<xref rid="B14" ref-type="bibr">14</xref>) revealed &#x0003e;50 putative clusters for secondary metabolite biosynthesis (see <xref rid="tabS1" ref-type="supplementary-material">Table&#x000a0;S1</xref> in the supplemental material). The chromosome of YIM 121038 harbored 42 BGCs, several of which could be associated with a high degree of certainty with known secondary metabolites. Most of the BGCs detected on the YIM 121038 chromosome (29 out of 42) had very close homologues in the genome of <italic toggle="yes">Streptomyces</italic> sp. strain MNP-20 and <italic toggle="yes">Streptomyces</italic> sp. strain NRRL B-1347. The linear plasmid of almost 1&#x02009;Mb in size was found to harbor 11 BGCs (<xref rid="tabS1" ref-type="supplementary-material">Table&#x000a0;S1</xref>). The BLAST analysis of single genes within the clusters suggested their unique origin, since no plausible hits could be found in the databases.</p><supplementary-material position="float" id="tabS1" content-type="local-data"><object-id pub-id-type="doi">10.1128/mbio.01789-22.6</object-id><label>TABLE&#x000a0;S1</label><p>Secondary metabolite biosynthetic gene clusters in the genome of <italic toggle="yes">Streptomyces</italic> sp. strain YIM 121038 predicted with antiSMASH 6.0 followed by manual curation. Shaded cells represent BGCs identified on the 1-Mb linear plasmid. Download <inline-supplementary-material id="tS1" xlink:href="mbio.01789-22-s0001.docx" content-type="local-data">Table&#x000a0;S1, DOCX file, 0.02 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2022 Schneider et al.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Schneider et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2022-08-30"/><license license-type="open-access"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="version-of-record">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material></sec><sec id="s2-2"><title>Identification of desertomycin A and its succinylated congener.</title><p>The methanolic mycelial extracts from the culture of <italic toggle="yes">Streptomyces</italic> sp. strain YIM 121038 exhibited antibacterial activity. To identify the compound(s) responsible for this activity, the extract was subjected to repetitive reversed-phase high-performance liquid chromatography (HPLC) to afford two compounds associated with fractions containing antibacterial activity, one of which had a predicted molecular formula of C<sub>65</sub>H<sub>113</sub>O<sub>24</sub>N as determined by high-resolution electrospray ionization mass spectrometry (HR-ESIMS) (<xref rid="figS1" ref-type="supplementary-material">Fig.&#x000a0;S1A</xref>). This compound was subjected to structure elucidation by means of nuclear magnetic resonance (NMR). The <sup>1</sup>H NMR and heteronuclear single quantum coherence (HSQC) spectra suggested that there were 7 doublet methyls, two singlet methyls, 8 protons attached to sp<sup>2</sup> carbons, and many oxygenated methines (<xref rid="figS1" ref-type="supplementary-material">Fig.&#x000a0;S1B to</xref> E). Correlation spectroscopy (COSY) correlations showed 10 units, a to j (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref>; <xref rid="figS2" ref-type="supplementary-material">Fig.&#x000a0;S2</xref>F and G). heteronuclear multiple-bond correlations (HMBCs) unambiguously revealed the mode of connections of those units (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1A</xref>; <xref rid="figS1" ref-type="supplementary-material">Fig.&#x000a0;S1</xref>H and I). The sugar moiety was attached to C-22, which was determined by HMBCs from H-22 to C-1&#x02032;. The presence of 46-NH was deduced by COSY correlations between H-46 and 46-NH measured in dimethyl sulfoxide (DMSO)-<italic toggle="yes">d</italic><sub>6</sub> (<xref rid="figS1" ref-type="supplementary-material">Fig.&#x000a0;S1G</xref>). Finally, the succinyl moiety was identified by HMBCs from H-2&#x02033;/3&#x02033; to C-1&#x02033;/C-4&#x02033; and shown to be attached to the N terminus of unit j by an HMBC from H-46 to C-1&#x02033;. The 38E geometry was determined by the large coupling constant (<sup>3</sup><italic toggle="yes">J</italic><sub>H38,H39</sub> = 15.7&#x02009;Hz). The 2E, 12E, 16E, and 20E geometries were elucidated by nuclear Overhauser effect spectroscopy (NOESY) correlations (<xref rid="figS1" ref-type="supplementary-material">Fig.&#x000a0;S1J</xref>). Compound 1 was found to be identical to the known antibiotic desertomycin A (<xref rid="B15" ref-type="bibr">15</xref>), except for the <italic toggle="yes">N</italic>-succinyl moiety, and was named desertomycin X.</p><fig position="float" id="fig1"><label>FIG&#x000a0;1</label><caption><p>Chemical structures of desertomycin A and its new derivative, desertomycin X, determined by NMR spectroscopy.</p></caption><graphic xlink:href="mbio.01789-22-f001" position="anchor"/></fig><supplementary-material position="float" id="figS1" content-type="local-data"><object-id pub-id-type="doi">10.1128/mbio.01789-22.1</object-id><label>FIG&#x000a0;S1</label><p>(A) HR-LC-ESIMS data of desertomycin X (compound 1). Shown is the mass spectrum of the peak at 13.66 min (<italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 1,292.7739 [M&#x02009;+&#x02009;H]<sup>+</sup>, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 1,274.7635 [M&#x02009;+&#x02009;H-H<sub>2</sub>O]<sup>+</sup>, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 1,256.7534 [M&#x02009;+&#x02009;H-2H<sub>2</sub>O]<sup>+</sup>, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 1,309.8000 [M+NH<sub>4</sub>]<sup>+</sup>, and <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 1314.7545 [M+Na]<sup>+</sup>). (B) <sup>1</sup>H NMR spectrum of desertomycin X in methanol-<italic toggle="yes">d</italic><sub>4</sub> at 500 MHz; (C) <sup>1</sup>H NMR spectrum of desertomycin X in DMSO-<italic toggle="yes">d</italic><sub>6</sub>; (D) HSQC spectrum of desertomycin X in methanol-<italic toggle="yes">d</italic><sub>4</sub> at 500 MHz; (E) HSQC spectrum of desertomycin X in DMSO-<italic toggle="yes">d</italic><sub>6</sub>; (F) COSY spectrum of desertomycin X in methanol-<italic toggle="yes">d</italic><sub>4</sub> at 500 MHz; (G) COSY spectrum of desertomycin X in DMSO-<italic toggle="yes">d</italic><sub>6</sub>; (H) HMBC spectrum of desertomycin X in methanol-<italic toggle="yes">d</italic><sub>4</sub> at 500 MHz; (I) HMBC spectrum of desertomycin X in DMSO-<italic toggle="yes">d</italic><sub>6</sub>; (J) NOESY spectrum of desertomycin X in methanol-<italic toggle="yes">d</italic><sub>4</sub> at 500 MHz. Download <inline-supplementary-material id="fS1" xlink:href="mbio.01789-22-s0005.pdf" content-type="local-data">FIG&#x000a0;S1, PDF file, 0.4 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2022 Schneider et al.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Schneider et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2022-08-30"/><license license-type="open-access"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="version-of-record">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material><supplementary-material position="float" id="figS2" content-type="local-data"><object-id pub-id-type="doi">10.1128/mbio.01789-22.2</object-id><label>FIG&#x000a0;S2</label><p>(A) HR-LC-ESIMS data of desertomycin A (compound 2). Shown is the mass spectrum of the peak at 12.87 min (<italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 1,192.7561 [M&#x02009;+&#x02009;H]<sup>+</sup> and <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 1,214.7377 [M+Na]<sup>+</sup>). (B) <sup>1</sup>H NMR spectrum of desertomycin A in methanol-<italic toggle="yes">d</italic><sub>4</sub> at 500 MHz; (C) HSQC spectrum of desertomycin A in methanol-<italic toggle="yes">d</italic><sub>4</sub> at 500 MHz; (D) COSY spectrum of desertomycin A in methanol-<italic toggle="yes">d</italic><sub>4</sub> at 600 MHz; (E) HMBC spectrum of desertomycin A in methanol-<italic toggle="yes">d</italic><sub>4</sub> at 600 MHz; (F) NOESY spectrum of desertomycin A in methanol-<italic toggle="yes">d</italic><sub>4</sub> at 600 MHz. Download <inline-supplementary-material id="fS2" xlink:href="mbio.01789-22-s0006.pdf" content-type="local-data">FIG&#x000a0;S2, PDF file, 0.3 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2022 Schneider et al.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Schneider et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2022-08-30"/><license license-type="open-access"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="version-of-record">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material><p>The second compound (compound 2) had a predicted molecular formula of C<sub>61</sub>H<sub>109</sub>O<sub>21</sub>N, which was determined by HR-ESIMS (<xref rid="figS2" ref-type="supplementary-material">Fig.&#x000a0;S2A</xref>). The <sup>1</sup>H NMR spectrum of this compound suggested that the signals at the lower magnetic field were nearly identical to those for compound 1 (<xref rid="figS2" ref-type="supplementary-material">Fig.&#x000a0;S2B</xref>), while the HSQC spectrum suggested the absence of the <italic toggle="yes">N</italic>-succinyl moiety compared to compound 1 (<xref rid="figS2" ref-type="supplementary-material">Fig.&#x000a0;S2C</xref>). The detailed analysis of the two-dimensional (2D) NMR data, including COSY, HMBC, and NOESY spectra, confirmed the structure of compound 2 as that of desertomycin A (<xref rid="figS2" ref-type="supplementary-material">Fig.&#x000a0;S2D to</xref> F). The chemical structures of the two desertomycin congeners are shown in <xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref>.</p></sec><sec id="s2-3"><title>Antimicrobial activity of the isolated compounds.</title><p>To test for antimicrobial activity, purified desertomycin A and desertomycin X were initially tested on Gram-positive and Gram-negative bacteria, as well as yeast and filamentous fungi, using a disk assay (see Materials and Methods for details). While desertomycin A inhibited the growth of both <named-content content-type="genus-species">Bacillus subtilis</named-content> and <named-content content-type="genus-species">Escherichia coli</named-content> (data not shown), desertomycin X was antibiotically inactive. This observation suggested that the succinyl group attached to the primary amine is detrimental for the antibacterial activity of desertomycin. In order to properly assess antibiotic activity of desertomycin A, it was tested, along with some clinically relevant antibiotics, on a panel of Gram-positive and Gram-negative bacteria using the broth microdilution method. This test did not reveal any measurable activity of desertomycin A against Gram-negative bacteria, including <named-content content-type="genus-species">E. coli</named-content>, at concentrations below 128&#x02009;&#x003bc;g/mL. This can be explained by different physiological conditions of bacterial cultures on the solid agar medium (initial disk assay) and in liquid cultures (CLSI method). At the same time, desertomycin A exhibited moderate activity against all of the Gram-positive bacteria tested, including <named-content content-type="genus-species">Staphylococcus aureus</named-content>, <named-content content-type="genus-species">Enterococcus faecium</named-content>, and <named-content content-type="genus-species">Streptococcus mutans</named-content> (<xref rid="tabS2" ref-type="supplementary-material">Table&#x000a0;S2</xref>).</p><supplementary-material position="float" id="tabS2" content-type="local-data"><object-id pub-id-type="doi">10.1128/mbio.01789-22.7</object-id><label>TABLE&#x000a0;S2</label><p>Antibacterial activity of desertomycin A and desertomycin X against Gram-positive bacteria. Download <inline-supplementary-material id="tS2" xlink:href="mbio.01789-22-s0002.docx" content-type="local-data">Table&#x000a0;S2, DOCX file, 0.01 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2022 Schneider et al.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Schneider et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2022-08-30"/><license license-type="open-access"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="version-of-record">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material></sec><sec id="s2-4"><title>Identification and characterization of CsbC as an <italic toggle="yes">N</italic>-succinyltransferase.</title><p>Since the <italic toggle="yes">N</italic>-succinylated congener desertomycin A was found to be antibiotically inactive, we focused on identification of an enzyme that might be responsible for the transformation of desertomycin A into desertomycin X. The desertomycin BGC (<xref rid="B16" ref-type="bibr">16</xref>) could be readily identified in the genome of YIM 121038. Since no genes coding for <italic toggle="yes">N</italic>-acyltransferases that could catalyze the aforementioned reaction were identified within the desertomycin cluster (BGC28) (<xref rid="tabS1" ref-type="supplementary-material">Table&#x000a0;S1</xref>), the YIM 121038 genome was manually mined for genes encoding GNAT-like proteins. A total of 36 genes encoding putative GNAT-like enzymes were identified, and their products, along with the MbtK GNAT-like protein from <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> known to bind succinyl-CoA (<xref rid="B17" ref-type="bibr">17</xref>) were used to construct a phylogenetic tree (<xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref>). One of the GNAT-like proteins, C9F11 29850, was found to be most closely related to MbtK and hence became the focus of further investigation.</p><fig position="float" id="fig2"><label>FIG&#x000a0;2</label><caption><p>Phylogenetic tree constructed by MEGAX software (<xref rid="B31" ref-type="bibr">31</xref>) for the GNAT-like proteins encoded by the <italic toggle="yes">Streptomyces</italic> sp. strain YIM 121038 genome using the maximum likelihood method. The analysis involved 37 amino acid sequences, including a proposed <italic toggle="yes">N</italic>-succinyltransferase of <named-content content-type="genus-species">M. tuberculosis</named-content>.</p></caption><graphic xlink:href="mbio.01789-22-f002" position="anchor"/></fig><p>The gene encoding C9F11 29850 was found within BGC20 (<xref rid="tab1" ref-type="table">Table&#x000a0;1</xref> and <xref rid="fig3" ref-type="fig">Fig.&#x000a0;3</xref>), which was predicted to specify the biosynthesis of a putative siderophore. The composition of genes in BGC20, designated <italic toggle="yes">csb</italic>, is similar to that of the <italic toggle="yes">iucABCD</italic> cluster in <named-content content-type="genus-species">E. coli</named-content> for the biosynthesis of the siderophore aerobactin (<xref rid="B18" ref-type="bibr">18</xref>), except for the <italic toggle="yes">iucD</italic>-like gene encoding <sc>l</sc>-lysine 6-monooxygenase, which is absent in the <italic toggle="yes">csb</italic> cluster. Instead, the <italic toggle="yes">csbA</italic> gene, presumably encoding diaminobutyrate-2-oxoglutarate transaminase, was identified, of which homologues are found in several siderophore BGCs in bacteria (<xref rid="B19" ref-type="bibr">19</xref>). Applying both a GNPS library search (<ext-link xlink:href="https://gnps.ucsd.edu" ext-link-type="uri">https://gnps.ucsd.edu</ext-link>) and targeted search for fragment ions typical for hydroxamate siderophores or the succinyl moiety on the liquid, chromatography-mass spectrometry (LC-MS) data of the liquid culture failed to uncover any potential product of <italic toggle="yes">csb</italic> or another siderophore-like compound.</p><fig position="float" id="fig3"><label>FIG&#x000a0;3</label><caption><p>Genetic organization of the cryptic siderophore biosynthesis gene cluster (BGC) <italic toggle="yes">csb</italic> in <italic toggle="yes">Streptomyces</italic> sp. strain YIM 121038, its closest homologues in other <italic toggle="yes">Streptomyces</italic> spp., and the <named-content content-type="genus-species">Escherichia coli</named-content> aerobactin BGC. DABA, diaminobutyrate-2-oxoglutarate transaminase; IucA/C, siderophore synthetase component; AT, <italic toggle="yes">N</italic>-acyltransferase; IucD, NADPH-dependent <sc>l</sc>-lysine <italic toggle="yes">N</italic>(6)-monooxygenase.</p></caption><graphic xlink:href="mbio.01789-22-f003" position="anchor"/></fig><table-wrap position="float" id="tab1"><label>TABLE&#x000a0;1</label><caption><p><italic toggle="yes">Streptomyces</italic> sp. strain YIM 121038 <italic toggle="yes">csb</italic> biosynthetic gene cluster</p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1">Gene</th><th rowspan="1" colspan="1">Product length (aa)</th><th rowspan="1" colspan="1">Protein homolog</th><th rowspan="1" colspan="1">Accession no.</th><th rowspan="1" colspan="1">Identity (%)</th><th rowspan="1" colspan="1">Proposed function</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<italic toggle="yes">orf1</italic>
</td><td rowspan="1" colspan="1">443</td><td rowspan="1" colspan="1">Hypothetical protein, <italic toggle="yes">Streptomyces</italic> sp. strain MNP-20</td><td rowspan="1" colspan="1">
<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_172386112.1" ext-link-type="uri" assigning-authority="ncbiprotein">WP_172386112.1</ext-link>
</td><td rowspan="1" colspan="1">99</td><td rowspan="1" colspan="1">Unknown</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">csbA</italic>
</td><td rowspan="1" colspan="1">545</td><td rowspan="1" colspan="1">Dat2, <italic toggle="yes">Streptomyces</italic> sp. strain MNP-20</td><td rowspan="1" colspan="1">
<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_172386144.1" ext-link-type="uri" assigning-authority="ncbiprotein">WP_172386144.1</ext-link>
</td><td rowspan="1" colspan="1">98</td><td rowspan="1" colspan="1">Diaminobutyrate-2-oxoglutarate transaminase</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">csbB</italic>
</td><td rowspan="1" colspan="1">818</td><td rowspan="1" colspan="1">IucA, <named-content content-type="genus-species">Streptomyces spectabilis</named-content></td><td rowspan="1" colspan="1">
<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_170316513.1" ext-link-type="uri" assigning-authority="ncbiprotein">WP_170316513.1</ext-link>
</td><td rowspan="1" colspan="1">83</td><td rowspan="1" colspan="1">Siderophore synthetase component</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">csbC</italic>
</td><td rowspan="1" colspan="1">258</td><td rowspan="1" colspan="1">IucB, <italic toggle="yes">Streptomyces</italic> sp. strain MNP-20</td><td rowspan="1" colspan="1">
<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_216678075.1?report=genpept" ext-link-type="uri">WP_216678075.1</ext-link>
</td><td rowspan="1" colspan="1">96</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic>-Acyltransferase</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">csbD</italic>
</td><td rowspan="1" colspan="1">615</td><td rowspan="1" colspan="1">IucC, <italic toggle="yes">Streptomyces</italic> sp. strain MNP-20</td><td rowspan="1" colspan="1">
<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_216678074.1?report=genpept" ext-link-type="uri">WP_216678074.1</ext-link>
</td><td rowspan="1" colspan="1">98</td><td rowspan="1" colspan="1">Siderophore synthetase component</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">orf2</italic>
</td><td rowspan="1" colspan="1">663</td><td rowspan="1" colspan="1">DinG, <italic toggle="yes">Streptomyces</italic> sp. strain MNP-20</td><td rowspan="1" colspan="1">
<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_172386109.1" ext-link-type="uri" assigning-authority="ncbiprotein">WP_172386109.1</ext-link>
</td><td rowspan="1" colspan="1">99</td><td rowspan="1" colspan="1">ATP-dependent DNA helicase</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">orf3</italic>
</td><td rowspan="1" colspan="1">261</td><td rowspan="1" colspan="1">LexA, multispecies of <italic toggle="yes">Streptomyces</italic></td><td rowspan="1" colspan="1">
<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_138962193.1" ext-link-type="uri" assigning-authority="ncbiprotein">WP_138962193.1</ext-link>
</td><td rowspan="1" colspan="1">100</td><td rowspan="1" colspan="1">Transcriptional regulator</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">orf4</italic>
</td><td rowspan="1" colspan="1">184</td><td rowspan="1" colspan="1">NrdR, <italic toggle="yes">Streptomyces</italic> sp. strain NRRL B-1347</td><td rowspan="1" colspan="1">
<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_030680473.1" ext-link-type="uri" assigning-authority="ncbiprotein">WP_030680473.1</ext-link>
</td><td rowspan="1" colspan="1">99</td><td rowspan="1" colspan="1">Transcriptional regulator</td></tr></tbody></table><graphic xlink:href="mbio.01789-22-t001" position="anchor"/></alternatives></table-wrap><p>The CsbC protein encoded by the <italic toggle="yes">csb</italic> cluster is a homolog of the IucB <italic toggle="yes">N</italic>-acetyltransferase and was predicted to catalyze the acetylation of <italic toggle="yes">N&#x02032;</italic>-hydroxylysine. Several attempts to inactivate the <italic toggle="yes">csbC</italic> gene in YIM121038 via gene disruption failed (data not shown), indicating that the product of <italic toggle="yes">csbC</italic>, or the <italic toggle="yes">csb</italic> cluster-specified siderophore, may be essential for this strain under the conditions used. To test our hypothesis that CsbC can succinylate desertomycin A, a codon-optimized <italic toggle="yes">csbC</italic> gene with an <italic toggle="yes">N</italic>-terminal His<sub>6</sub> tag was expressed in <named-content content-type="genus-species">E. coli</named-content> BL21(DE3) and purified, and its <italic toggle="yes">N</italic>-succinyltransferase activity was tested with desertomycin A. In the <italic toggle="yes">in vitro</italic> enzyme assay, formation of desertomycin X was confirmed using LC-tandem MS (MS/MS) analysis of the reaction mixture (<xref rid="figS3" ref-type="supplementary-material">Fig.&#x000a0;S3A</xref>).</p><supplementary-material position="float" id="figS3" content-type="local-data"><object-id pub-id-type="doi">10.1128/mbio.01789-22.3</object-id><label>FIG&#x000a0;S3</label><p>(A) CsbC <italic toggle="yes">in vitro</italic> activity on desertomycin A (Des A). Total ion chromatograms (<italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 140 to 2,000) of the reaction mixture containing CsbC, desertomycin A, and either succinyl (S) coenzyme A (a and b) or acetyl (Ac) coenzyme A (c) obtained by LC-MS in positive-ion mode. The reaction was quenched either before (a) or after (b and c) incubation for 2 h at 30&#x000b0;C&#x02014;the former as a negative control. Desertomycin X (Des X) is the <italic toggle="yes">N</italic>-succinylated derivative of Des A. (b) CsbC <italic toggle="yes">in vitro</italic> activity on daptomycin. Shown are total ion chromatograms (<italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 140 to 2,000) of the reaction mixture containing CsbC, succinyl coenzyme A, and daptomycin (Dap) obtained by LC-MS in positive-ion mode. The reaction was quenched either before (a) or after (b) incubation for 2 h at 30&#x000b0;C&#x02014;the former as a negative control. (C) CsbC <italic toggle="yes">in vitro</italic> activity on ethionamide (Eth). Shown are the extracted ion chromatograms for <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 167.0637&#x02009;&#x000b1;&#x02009;0.0017 (black line) and <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 267.0798&#x02009;&#x000b1;&#x02009;0.0027 (red line) of the reaction mixture containing CsbC, succinyl coenzyme A, and ethionamide (Eth) obtained by LC-MS in positive-ion mode. The reaction was quenched either before (a) or after (b) incubation for 2 h at 30&#x000b0;C&#x02014;the former as negative control. (D) CsbC <italic toggle="yes">in vitro</italic> activity on trimethoprim (Tri). Shown are extracted ion chromatograms for <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 291.1452&#x02009;&#x000b1;&#x02009;0.0029 (black line) and <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 391.1612&#x02009;&#x000b1;&#x02009;0.0039 (red line) of the reaction mixture containing CsbC, succinyl coenzyme A, and trimethoprim obtained by LC-MS in positive-ion mode. The reaction was quenched either before (a) or after (b) incubation for 2 h at 30&#x000b0;C&#x02014;the former as a negative control. (E) CsbC <italic toggle="yes">in vitro</italic> activity on vancomycin (Van). Shown are extracted ion chromatograms for <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 724.7224&#x02009;&#x000b1;&#x02009;0.0072 (black line), <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 774.7304&#x02009;&#x000b1;&#x02009;0.0077 (red line), and <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 824.7384&#x02009;&#x000b1;&#x02009;0.0082 (green line) of the reaction mixture containing CsbC, succinyl coenzyme A, and vancomycin obtained by LC-MS in positive-ion mode. The reaction was quenched either before (a) or after (b) incubation for 2 h at 30&#x000b0;C&#x02014;the former as a negative control. (F) CsbC <italic toggle="yes">in vitro</italic> activity on colistin (Col). Shown are extracted ion chromatograms for <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 578.3822&#x02009;&#x000b1;&#x02009;0.0058 (black line), <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 628.3903&#x02009;&#x000b1;&#x02009;0.0063 (red line), <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 678.3983&#x02009;&#x000b1;&#x02009;0.0068 (green line), <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 728.4063&#x02009;&#x000b1;&#x02009;0.0073 (blue line), <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 778.4143&#x02009;&#x000b1;&#x02009;0.0078 (beige line), and <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 828.4224&#x02009;&#x000b1;&#x02009;0.0083 (purple line) of the reaction mixture containing CsbC, succinyl coenzyme A, and colistin obtained by LC-MS in positive-ion mode. The reaction was quenched either before (a) or after (b) incubation for 2 h at 30&#x000b0;C&#x02014;the former as a negative control. (G) CsbC <italic toggle="yes">in vitro</italic> activity on tetracycline (Tet). Shown are extracted ion chromatograms for <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 445.1605&#x02009;&#x000b1;&#x02009;0.0045 (black line), and <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 545.1766&#x02009;&#x000b1;&#x02009;0.0055 (red line) of the reaction mixture containing CsbC, succinyl coenzyme A, and tetracycline obtained by LC-MS in positive-ion mode. The reaction was quenched either before (a) or after (b) incubation for 2 h at 30&#x000b0;C&#x02014;the former as negative control. (H) CsbC <italic toggle="yes">in vitro</italic> activity on gentamicin (Gen). HR-ESI mass spectra (<italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 200 to 700, retention time [RT] 0.40 to 3.44 min) of the reaction mixture containing CsbC, succinyl coenzyme A, and gentamicin obtained by LC-MS in positive-ion mode. The reaction was quenched either before (a) or after (b) incubation for 2 h at 30&#x000b0;C&#x02014;the former as a negative control. (I) CsbC <italic toggle="yes">in vitro</italic> acetylation activity on kanamycin (Kan). High-resolution ESI mass spectra (<italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 450 to 600, RT 0.40 to 4.00 min) of the reaction mixture containing CsbC, acetyl (Ac) coenzyme A, and kanamycin obtained by LC-MS in positive-ion mode. The reaction was quenched either before (a) or after (b) incubation for 2 h at 30&#x000b0;C&#x02014;the former as a negative control. (J) CsbC <italic toggle="yes">in vitro</italic> activity on ornithine (Orn). Shown are extracted ion chromatograms for <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 133.0972&#x02009;&#x000b1;&#x02009;0.0050 (black line), <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 233.1132&#x02009;&#x000b1;&#x02009;0.0050 (red line), and <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 333.1292&#x02009;&#x000b1;&#x02009;0.0050 (green line) of the reaction mixture containing CscB-S, succinyl coenzyme A, and ornithine obtained by LC-MS in positive-ion mode. The reaction was quenched either before (a) or after (b) incubation for 2 h at 30&#x000b0;C&#x02014;the former as a negative control. (K) CsbC <italic toggle="yes">in vitro</italic> activity on putrescine (Put). Shown are total ion chromatograms (<italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 60 to 1,500) of the reaction mixture containing CscB-S, succinyl coenzyme A, and putrescine obtained by LC-MS in positive-ion mode. The reaction was quenched either before (a) or after (b) incubation for 2 h at 30&#x000b0;C&#x02014;the former as a negative control. Download <inline-supplementary-material id="fS3" xlink:href="mbio.01789-22-s0007.pdf" content-type="local-data">FIG&#x000a0;S3, PDF file, 0.6 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2022 Schneider et al.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Schneider et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2022-08-30"/><license license-type="open-access"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="version-of-record">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material></sec><sec id="s2-5"><title>CsbC-catalyzed inactivation of antibiotics and its substrate specificity <italic toggle="yes">in vitro</italic>.</title><p>Based on the fact that desertomycin X did not show any antibacterial activity in the bioassays, we further hypothesized that <italic toggle="yes">N</italic>-succinylation by CsbC might represent a resistance mechanism. We next tested eight structurally diverse antibiotics in the <italic toggle="yes">in vitro</italic> succinylation reactions involving recombinant CsbC, followed by bioassays and LC-MS/MS analyses. Colistin, kanamycin, daptomycin, gentamicin (<xref rid="fig4" ref-type="fig">Fig.&#x000a0;4</xref>), and ampicillin (see <xref rid="fig6" ref-type="fig">Fig. 6B</xref>) lost their activity after treatment with CsbC, while no significant changes in antibiotic activity were observed for trimethoprim, tetracycline, and vancomycin in these assays (<xref rid="fig4" ref-type="fig">Fig.&#x000a0;4</xref>). Some decrease in bioactivity was detected for the reaction mixture with desertomycin A as a substrate. The antimicrobial activity of ethionamide was not tested in the bioassay, and succinylation of this compound was analyzed with LC-MS only (<xref rid="tab2" ref-type="table">Table&#x000a0;2</xref>). Extracted ion chromatograms for ampicillin and mass spectra for kanamycin treated with CbsC and showing efficient conversion of the two antibiotics to succinylated derivatives are shown in <xref rid="fig5" ref-type="fig">Fig.&#x000a0;5</xref>.</p><fig position="float" id="fig4"><label>FIG&#x000a0;4</label><caption><p>Diffusion disc bioactivity test of various antibiotics after incubation with CsbC and succinyl-CoA. The trimethoprim and colistin samples were tested against <named-content content-type="genus-species">E. coli</named-content>, while the samples with kanamycin, desertomycin, tetracycline, daptomycin, vancomycin, and gentamicin were tested against <named-content content-type="genus-species">B. subtilis</named-content>. &#x0201c;Den&#x0201d; (CsbC denatured) indicates samples with 0.5% formic acid added to inactivate the enzyme before addition of antibiotics, which were used as negative controls. &#x0201c;Nat&#x0201d; (CsbC native) denotes samples with native enzyme where the same amount of formic acid was added after the reaction was finished.</p></caption><graphic xlink:href="mbio.01789-22-f004" position="anchor"/></fig><fig position="float" id="fig5"><label>FIG&#x000a0;5</label><caption><p>CsbC <italic toggle="yes">in vitro</italic> activity on ampicillin (A&#x02013;C) and kanamycin (D&#x02013;F). Extracted ion chromatograms for <italic toggle="yes">m/z</italic> 350.1169 &#x000b1; 0.0035 (black line, corresponding to Amp) and <italic toggle="yes">m/z</italic> 450.1329 &#x000b1; 0.0045 (red line, corresponding to succinylated Amp) of the reaction mixture containing CsbC, ampicillin (Amp), and succinyl (S) coenzyme A (A and B) or acetyl (Ac) coenzyme A (C) obtained by LC-MS in positive ion mode. The reaction was quenched either before (A) or after (B and C) incubation for 2 h at 30 &#x000b0;C &#x02013; the former as negative control. High resolution ESI mass spectra (<italic toggle="yes">m/z</italic> 400-920, average over Rt 0.40-4.00 min) of the reaction mixture containing CsbC, succinyl (S) coenzyme A, and kanamycin (Kan) obtained by LC-MS in positive ion mode. The reaction was quenched either before (A) or after (B and C) incubation for 2 h at 30 &#x000b0;C &#x02013; the former as negative control. Inhibition of CsbC by pefloxacin was tested by addition of 1 mM pefloxacin mesylate dehydrate to the reaction mixture (C).</p></caption><graphic xlink:href="mbio.01789-22-f005" position="anchor"/></fig><table-wrap position="float" id="tab2"><label>TABLE&#x000a0;2</label><caption><p><italic toggle="yes">N</italic>-Succinylation of the tested antibiotics by recombinant CsbC protein</p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th rowspan="2" colspan="1">Tested substrate</th><th colspan="3" rowspan="1">No. of:<hr/></th></tr><tr><th rowspan="1" colspan="1">Primary/secondary aliphatic amine groups</th><th rowspan="1" colspan="1">Aromatic amine groups</th><th rowspan="1" colspan="1">Succinyl groups added by CsbC</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Ampicillin</td><td rowspan="1" colspan="1">1/0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">1</td></tr><tr><td rowspan="1" colspan="1">Colistin</td><td rowspan="1" colspan="1">5/0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">1&#x02013;5</td></tr><tr><td rowspan="1" colspan="1">Daptomycin</td><td rowspan="1" colspan="1">1/0</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">1</td></tr><tr><td rowspan="1" colspan="1">Desertomycin A</td><td rowspan="1" colspan="1">1/0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">1</td></tr><tr><td rowspan="1" colspan="1">Ethionamide</td><td rowspan="1" colspan="1">0/0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1">Gentamicin</td><td rowspan="1" colspan="1">3/2<xref rid="ngtab2-1" ref-type="table-fn"><sup><italic toggle="yes">a</italic></sup></xref></td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">1&#x02013;3 (4 in traces)</td></tr><tr><td rowspan="1" colspan="1">Kanamycin</td><td rowspan="1" colspan="1">4/0<xref rid="ngtab2-2" ref-type="table-fn"><sup><italic toggle="yes">b</italic></sup></xref></td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">1&#x02013;4</td></tr><tr><td rowspan="1" colspan="1">Tetracycline</td><td rowspan="1" colspan="1">0/0<xref rid="ngtab2-3" ref-type="table-fn"><sup><italic toggle="yes">c</italic></sup></xref></td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">1</td></tr><tr><td rowspan="1" colspan="1">Trimethoprim</td><td rowspan="1" colspan="1">0/0</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1 (traces)</td></tr><tr><td rowspan="1" colspan="1">Vancomycin</td><td rowspan="1" colspan="1">1/1</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">1 (2 in traces)</td></tr></tbody></table><graphic xlink:href="mbio.01789-22-t002" position="anchor"/></alternatives><table-wrap-foot><fn fn-type="other" id="ngtab2-1"><label>a</label><p>For gentamicin C<sub>1</sub>.</p></fn><fn fn-type="other" id="ngtab2-2"><label>b</label><p>For kanamycins A and C.</p></fn><fn fn-type="other" id="ngtab2-3"><label>c</label><p>One tertiary aliphatic amine that cannot be succinylated.</p></fn></table-wrap-foot></table-wrap><p>The selectivity of CsbC toward the acyl group donor was tested by substituting for succinyl-CoA with acetyl-CoA in the <italic toggle="yes">in vitro</italic> reactions. The antibiotic activities of the ampicillin and kanamycin that were used in this experiment were not affected when acetyl-CoA was used (<xref rid="fig6" ref-type="fig">Fig.&#x000a0;6A</xref>), in contrast to what was observed with succinyl-CoA as cosubstrate (<xref rid="fig6" ref-type="fig">Fig.&#x000a0;6B</xref>). Hence, it was concluded that the latter acyl-CoA is the preferred CsbC acyl donor under the conditions tested.</p><fig position="float" id="fig6"><label>FIG&#x000a0;6</label><caption><p>Comparison of CsbC selectivity for the substrates acetyl-CoA (AcCoA) (A) and succinyl-CoA (SCoA) (B) tested in acylation reactions with ampicillin (Amp) and kanamycin (Kan). The diffusion disc assay test was applied with <named-content content-type="genus-species">E. coli</named-content> for Amp and <named-content content-type="genus-species">B. subtilis</named-content> for Kan. Samples with 0.5% formic acid (to inactivate the enzyme before addition of antibiotics, where &#x0201c;Den&#x0201d; represents CsbC-S denatured) were used as negative controls. The same amount of formic acid was added to the samples with native CsbC-S enzyme (Nat) after the reaction was finished.</p></caption><graphic xlink:href="mbio.01789-22-f006" position="anchor"/></fig><p>In line with the observed decrease in antibiotic activity, colistin, kanamycin, and ampicillin were found by the LC-MS analysis to be the most favored substrates of CsbC. In all three cases, the signal intensities of the succinylated derivatives were higher than the ones of the remaining nonmodified antibiotics. Desertomycin A, gentamicin, daptomycin, tetracycline, and vancomycin were succinylated to a lesser extent, while ethionamide and trimethoprim were barely or not at all accepted as the substrates (<xref rid="figS3" ref-type="supplementary-material">Fig.&#x000a0;S3A</xref> to <xref rid="figS3" ref-type="supplementary-material">H</xref>). These results strongly suggest that sterically unhindered aliphatic amine groups are preferred sites of modification by CsbC, while aromatic amine groups are not or only very weak acceptors (<xref rid="tab2" ref-type="table">Table&#x000a0;2</xref>). This activity is not restricted to antibiotics, as was confirmed by the formation of <italic toggle="yes">N</italic>- and <italic toggle="yes">N</italic>,<italic toggle="yes">N&#x02032;</italic>-succinylated derivatives of the antibiotically inactive primary metabolites putrescine and ornithine (<xref rid="figS3" ref-type="supplementary-material">Fig.&#x000a0;S3</xref>J and K).</p><p>According to the MS/MS spectra, the preferred succinylation site in vancomycin is the secondary amine on the glycopeptide&#x02019;s N terminus (data not shown), presumably because the primary amine is localized on a sterically hindered tertiary carbon. In the case of tetracycline, where we would expect no amide formation to occur, the small amount of detected succinylation is apparently due to the formation of an ester with an nonphenolic OH group, as demonstrated by an [M-C<sub>4</sub>H<sub>6</sub>O<sub>4</sub>+H]<sup>+</sup> fragment ion in the MS/MS spectrum (data not shown). Presumably, this reaction is also catalyzed by CsbC, since no such product is observed in the reaction mixtures quenched with formic acid (FA) before incubation.</p><p>According to the LC-MS analyses, acetyl-CoA can be used by CsbC as acyl-group donor instead of succinyl-CoA for some of the tested antibiotics, but generally with a much lower efficiency. Acetylated products were detected for kanamycin (<xref rid="figS3" ref-type="supplementary-material">Fig.&#x000a0;S3I</xref>), desertomycin A (<xref rid="figS3" ref-type="supplementary-material">Fig.&#x000a0;S3A</xref>), and, to a very low extent, for vancomycin, but not for ampicillin and daptomycin (data not shown).</p><p>To test whether the formation of desertomycin X by CsbC is related to self-resistance, its production in relation to desertomycin A was followed over 6&#x02009;days of cultivation, whereby the culture medium and the cell pellet were separated before extraction. <italic toggle="yes">Streptomyces</italic> sp. strain YIM 121038 was found to be a very prolific producer of desertomycin A, with high levels being detected already after 1&#x02009;day of cultivation in both the pellet and the supernatant (<xref rid="figS4" ref-type="supplementary-material">Fig.&#x000a0;S4A to</xref> F). Relevant amounts of desertomycin X were only detected at day 2, but at low levels compared to desertomycin A. Furthermore, <italic toggle="yes">N</italic>-acetyl desertomycin A was produced at even higher levels than desertomycin X. The concentrations of all three congeners did not increase much or even decrease again after 2&#x02009;days of fermentation under the given conditions. Interestingly, the relative abundance of desertomycin X compared to desertomycin A and <italic toggle="yes">N</italic>-acetyl desertomycin A was much higher in the supernatant. None of these findings are in line with <italic toggle="yes">N</italic>-succinylation or <italic toggle="yes">N</italic>-acetylation of desertomycin A being relevant for self-resistance, but fit the low affinity of CsbC for desertomycin A found <italic toggle="yes">in vivo</italic>. The LC-MS data from the whole extracts also revealed the isomerization of all three congeners over time, particularly in the supernatant.</p><supplementary-material position="float" id="figS4" content-type="local-data"><object-id pub-id-type="doi">10.1128/mbio.01789-22.4</object-id><label>FIG&#x000a0;S4</label><p>(A) Monitoring the production of desertomycin congeners in <italic toggle="yes">Streptomyces</italic> sp. strain YIM 121038 over 6 days of cultivation in TSB medium. Base peak chromatograms (<italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 100 to 2,000) of the cell pellet extract after 1 (a), 2 (b), 3 (c), 4 (d), and 6 (e) days of fermentation. Desertomycin A (Des A), desertomycin X (Des X), <italic toggle="yes">N</italic>-acetyl desertomycin A (Ac-Des A), and uncharacterized isomers of them (Des A&#x02032;, Des X&#x02032;, Ac-Des A&#x02032;) were identified. (B) Monitoring the production of desertomycin congeners in <italic toggle="yes">Streptomyces</italic> sp. strain YIM 121038 over 6 days of cultivation in TSB medium. Shown are extracted ion chromatograms of the cell pellet extract for the [M&#x02009;+&#x02009;H]<sup>+</sup> ions of desertomycin A (<italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 1,192.7565&#x02009;&#x000b1;&#x02009;0.0100 [green line]), desertomycin X (<italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 1,292.7725&#x02009;&#x000b1;&#x02009;0.0100 [dark red line]), and <italic toggle="yes">N</italic>-acetyl desertomycin A (<italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 1,234.7671&#x02009;&#x000b1;&#x02009;0.0100 [blue line]) after 1 (a), 2 (b), 3 (c), 4 (d), and 6 (e) days of fermentation. (C) Monitoring the production of desertomycin congeners in <italic toggle="yes">Streptomyces</italic> sp. strain YIM 121038 over 6 days of cultivation in TSB medium. Base peak chromatograms (<italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 100 to 2,000) of the supernatant extract after 1 (a), 2 (b), 3 (c), 4 (d), and 6 (e) days of fermentation. Desertomycin A, desertomycin X, <italic toggle="yes">N</italic>-acetyl desertomycin A, and uncharacterized isomers of them were identified. (D) Monitoring the production of desertomycin congeners in <italic toggle="yes">Streptomyces</italic> sp. strain YIM 121038 over 6 days of cultivation in TSB medium. Shown are extracted ion chromatograms of the supernatant extract for the [M&#x02009;+&#x02009;H]<sup>+</sup> ions of desertomycin A (<italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 1,192.7565&#x02009;&#x000b1;&#x02009;0.0100 [green line]), desertomycin X (<italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 1,292.7725&#x02009;&#x000b1;&#x02009;0.0100 [dark red line]), and <italic toggle="yes">N</italic>-acetyl desertomycin A (<italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 1,234.7671&#x02009;&#x000b1;&#x02009;0.0100 [blue line]) after 1 (a), 2 (b), 3 (c), 4 (d), and 6 (e) days of fermentation. (E) Monitoring the production of desertomycin congeners in <italic toggle="yes">Streptomyces</italic> sp. strain YIM 121038 over 6 days of cultivation in TSB medium. Peak areas were obtained from the extracted ion chromatograms of the cell pellet extract for the [M&#x02009;+&#x02009;H]<sup>+</sup> ions of desertomycin A, desertomycin X, <italic toggle="yes">N</italic>-acetyl desertomycin A, and uncharacterized isomers of them. The weight of freeze-dried supernatant was determined before extraction. (F) Monitoring the production of desertomycin congeners in <italic toggle="yes">Streptomyces</italic> sp. strain YIM 121038 over 6 days of cultivation in TSB medium. Peak areas were obtained from the extracted ion chromatograms of the supernatant extract for the [M&#x02009;+&#x02009;H]<sup>+</sup> ions of desertomycin A, desertomycin X, <italic toggle="yes">N</italic>-acetyl desertomycin A, and the uncharacterized isomers of them. The weight of the freeze-dried pellet was determined before extraction. Download <inline-supplementary-material id="fS4" xlink:href="mbio.01789-22-s0008.pdf" content-type="local-data">FIG&#x000a0;S4, PDF file, 0.7 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2022 Schneider et al.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Schneider et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2022-08-30"/><license license-type="open-access"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="version-of-record">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material></sec><sec id="s2-6"><title>CsbC provides for low-level kanamycin and ampicillin resistance <italic toggle="yes">in vivo</italic>.</title><p>The results of the <italic toggle="yes">in vitro</italic> studies supported our hypothesis that CsbC can catalyze the attachment of a succinyl moiety to various antibiotics with amino groups and that, in some cases, this modification can lead to the entire loss of antibiotic activity. Considering this, we tested the kanamycin resistance of an <named-content content-type="genus-species">S. lividans</named-content> TK24/pUWL-<italic toggle="yes">csbC</italic> strain, which expresses the native <italic toggle="yes">csbC</italic> gene. Growth of <named-content content-type="genus-species">S. lividans</named-content> TK24/pUWL-<italic toggle="yes">csbC</italic> in liquid medium and on the agar plates with up to 7&#x02009;&#x003bc;g/mL of kanamycin (concentration causing complete growth inhibition) was monitored. No differences in growth could be detected compared to the control strain <named-content content-type="genus-species">S. lividans</named-content> TK24/pUWLoriT (empty vector) and the strain expressing <italic toggle="yes">csbC</italic>.</p><p>Next, kanamycin resistance of <named-content content-type="genus-species">E. coli</named-content> BL21/pA_CsbC, which harbors a vector with an ampicillin resistance gene and provides for IPTG (isopropyl-&#x003b2;-<sc>d</sc>-thiogalactopyranoside)-inducible CsbC expression, was tested. It was expected that after addition of IPTG, the production of recombinant CsbC will be induced and the intracellular kanamycin will be inactivated via <italic toggle="yes">N</italic>-succinylation. After 24 h of cultivation in the kanamycin-supplemented medium with and without IPTG induction, the BL21/pA_CsbC strain grew considerably better than the control strain BL21/pA (<xref rid="fig7" ref-type="fig">Fig.&#x000a0;7A</xref>). At the same time, it was obvious that induction with IPTG significantly suppresses the bacterial growth of both the CsbC-expressing strain and the control strain. Western blot analysis of samples demonstrated a weak expression of CsbC in BL21/pA_CsbC cultures, even without IPTG addition, indicating T7 promoter leakage (<xref rid="fig7" ref-type="fig">Fig.&#x000a0;7B</xref>). Apparently, this weak expression was nevertheless sufficient to enhance resistance of strain BL21/pA_CsbC to kanamycin.</p><fig position="float" id="fig7"><label>FIG&#x000a0;7</label><caption><p>Development of kanamycin resistance in <named-content content-type="genus-species">E. coli</named-content> BL21 after expression of CsbC <italic toggle="yes">in vivo</italic>. (A) Bacterial growth after 24-h cultivation in LB medium with 0 and 5&#x02009;&#x003bc;g/mL kanamycin (Kan) and with/without IPTG induction; (B) Western blot analysis of crude extracts from panel A and comparison to 2.6&#x02009;&#x003bc;g of purified CsbC protein. pA, empty vector; pA_CsbC, IPTG-inducible CsbC-expressing vector.</p></caption><graphic xlink:href="mbio.01789-22-f007" position="anchor"/></fig><p>The development of a weak resistance in BL21/pET-CsbC cells was also detected in the experiment with ampicillin. Here, we could show that with all tested ampicillin concentrations, the strain carrying the CsbC-expressing vector grew better than the control <named-content content-type="genus-species">E. coli</named-content> BL21 strain with the pET30a(+) vector (<xref rid="fig8" ref-type="fig">Fig.&#x000a0;8</xref>). The difference in growth between the two strains could be best seen in medium containing the smallest amounts of Amp (5 and 10&#x02009;&#x003bc;g/mL). Due to the fact that CsbC showed a broad substrate specificity, we decided to study its kinetics in reaction with ampicillin as the substrate. The initial idea of using kanamycin as a substrate was rejected due to the presence of several amino groups that were apparently modified by this enzyme. Ampicillin, on the contrary, harbors only one amino group, which makes the analysis more precise than that with kanamycin. <italic toggle="yes">V</italic><sub>max</sub> and <italic toggle="yes">K<sub>m</sub></italic> constants were determined based on the formation of <italic toggle="yes">N</italic>-succinylated ampicillin (Amp-S), the concentration of which was calculated from the data from HPLC analysis (<xref rid="figS5" ref-type="supplementary-material">Fig.&#x000a0;S5</xref>). The Microsoft Excel Solver was applied in this calculation to increase the accuracy of data interpretation, which resulted in calculated values for of 0.47&#x02009;mM for <italic toggle="yes">K<sub>m</sub></italic> and 0.61&#x02009;mM/min for <italic toggle="yes">V</italic><sub>max</sub>.</p><fig position="float" id="fig8"><label>FIG&#x000a0;8</label><caption><p>Development of ampicillin resistance in <named-content content-type="genus-species">E. coli</named-content> BL21 after expression of CsbC <italic toggle="yes">in vivo</italic> with the pET30a(+) expression system. Bacterial growth after 24-h cultivation in LB medium with 0 to 50&#x02009;&#x003bc;g/mL ampicillin (Amp) and with 0.1&#x02009;mM IPTG induction was monitored via OD<sub>600</sub> measurements.</p></caption><graphic xlink:href="mbio.01789-22-f008" position="anchor"/></fig><supplementary-material position="float" id="figS5" content-type="local-data"><object-id pub-id-type="doi">10.1128/mbio.01789-22.5</object-id><label>FIG&#x000a0;S5</label><p>Enzyme kinetic analysis of CsbC-S. Plotted are raw data of activity measurements against different ampicillin concentrations and a Solver plot with determined <italic toggle="yes">V</italic><sub>max</sub> and <italic toggle="yes">K<sub>m</sub></italic> values according to the Solver analysis tool. Download <inline-supplementary-material id="fS5" xlink:href="mbio.01789-22-s0009.pdf" content-type="local-data">FIG&#x000a0;S5, PDF file, 0.3 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2022 Schneider et al.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Schneider et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2022-08-30"/><license license-type="open-access"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="version-of-record">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material></sec></sec><sec sec-type="discussion" id="s3"><title>DISCUSSION</title><p>It is now widely acknowledged that antibiotic resistance genes have most likely originated from antibiotic-producing bacteria, which had to protect themselves from the action of endogenously produced antibiotics (<xref rid="B20" ref-type="bibr">20</xref>). In this work, we identified in a <italic toggle="yes">Streptomyces</italic> sp. a new congener of the known antibiotic desertomycin A, designated desertomycin X, which is antibiotically inactive and only differs from the former by the presence of an <italic toggle="yes">N-</italic>succinyl group. This suggested that <italic toggle="yes">N</italic>-succinylation may represent a previously undescribed resistance mechanism. Although resistance genes are in most cases colocalized with the antibiotic biosynthesis genes, no such gene, which would presumably encode an <italic toggle="yes">N-</italic>succinyltransferase, was found in the desertomycin biosynthesis gene cluster. The search for a possible candidate led us to examine a BGC termed <italic toggle="yes">csb</italic> that specifies the biosynthesis of a cryptic siderophore. A putative GNAT family acyltransferase encoded by the <italic toggle="yes">csbC</italic> gene in this cluster distinguished itself from known <italic toggle="yes">N-</italic>acyltransferases that use acetyl-CoA as acyl group donor to modify and inactivate certain antibiotics, such as aminoglycosides (<xref rid="B7" ref-type="bibr">7</xref>). In particular, CsbC had an ca. 80-amino-acid-extended N terminus which contained a polyproline signature, a feature found only in homologous uncharacterized proteins encoded by similar BGCs in 3 <italic toggle="yes">Streptomyces</italic> spp. CsbC contains domains with similarity to the AAC(6&#x02032;) protein Rv1347c, which was suggested by Card et al. to be involved in both antibiotic resistance and mycobactin biosynthesis in <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> (<xref rid="B17" ref-type="bibr">17</xref>). However, neither role of the Rv1347c protein was experimentally verified in enzyme assays with acetyl-CoA, propionyl-CoA, and butyryl-CoA. We hypothesized that CsbC may be responsible for the <italic toggle="yes">N-</italic>succinylation of desertomycin A, which was confirmed via expression of recombinant CsbC in <named-content content-type="genus-species">E. coli</named-content> followed by <italic toggle="yes">N-</italic>acylation activity testing <italic toggle="yes">in vitro</italic>. Moreover, CsbC could efficiently <italic toggle="yes">N-</italic>succinylate structurally distinct antibiotics as well as some primary metabolites. Some of those, in which an amino group important for interaction with the molecular target was blocked via succinylation, lost all or most of their antibiotic activity. Acetyl-CoA, however, could not be used by CsbC as an acyl group donor as efficiently as succinyl-CoA in our experiments.</p><p>Next, we tested the ability of CsbC to confer antibiotic resistance <italic toggle="yes">in vivo</italic>. Expression of the native, non-codon-optimized <italic toggle="yes">csbC</italic> in <named-content content-type="genus-species">S. lividans</named-content> did not lead to increased kanamycin resistance in this bacterium. This may be explained either by the lower pool of freely available succinyl-CoA in this bacterium under the conditions tested or by the low expression of the elongation factor P known to be essential for the synthesis of proteins with polyproline motifs (<xref rid="B21" ref-type="bibr">21</xref>). However, the fact that antibiotically inactive <italic toggle="yes">N</italic>-succinylated congener of desertomycin A was isolated from <italic toggle="yes">Streptomyces</italic> sp. strain YIM 121038 suggests that CsbC is active <italic toggle="yes">in vivo</italic> and may contribute to the antibiotic resistance in natural environment. Notably, the recombinant CsbC was able to confer kanamycin and ampicillin resistance in <named-content content-type="genus-species">E. coli</named-content>, albeit only to a low level. In the experiment with kanamycin, it was apparent that IPTG-induced CsbC expression detrimentally affected the growth of recombinant <named-content content-type="genus-species">E. coli</named-content> BL21, most likely due to the overexpression of T7 polymerase (<xref rid="B22" ref-type="bibr">22</xref>), but maybe also due to the depletion of succinyl-CoA, which is a less abundant cellular metabolite than acetyl-CoA (<xref rid="B23" ref-type="bibr">23</xref>). Another explanation could be succinylation of primary metabolites, such as putrescine and ornithine (see the Results section), that would render them unsuitable for anabolic pathways. However, we did not observe such an effect in the experiment with ampicillin, which speaks in favor of the former hypothesis of succinyl-CoA depletion. (Kanamycin can accept four succinyl moieties, while ampicillin accepts only one.)</p><p>Concentrations of antibiotics in natural, nonpolluted environmental samples, such as soil and water, are presumed to be very low, and the physiology of bacteria dwelling in these environments must differ significantly from that when bacteria are cultivated in the laboratory (<xref rid="B24" ref-type="bibr">24</xref>). Considering this, it seems plausible that <italic toggle="yes">csbC</italic> homologues, while encoding an essential part of the siderophore biosynthesis pathway, may at the same time confer antibiotic resistance in the natural environment. Targeting CsbC-like proteins for inhibition may thus have a dual effect on the viability of bacteria due to both the depletion of essential ions and prevention of the antibiotic resistance phenotype.</p></sec><sec sec-type="materials|methods" id="s4"><title>MATERIALS AND METHODS</title><sec id="s4-1"><title>Isolation and identification of <italic toggle="yes">Streptomyces</italic> sp. strain YIM 121038.</title><p>The soil sample was collected in May 2012 in the tropical rain forest in Xishuangbanna, Yunnan Province, People&#x02019;s Republic of China, at an altitude of 488 m and latitude and longitude N21&#x000b0;30&#x02032;, E100&#x000b0;46&#x02032;. <italic toggle="yes">Streptomyces</italic> sp. strain YIM 121038 was isolated by using YIM 171 medium (raffinose, 5.0 g/L; histidine, 1.0 g/L; K<sub>2</sub>HPO<sub>4</sub>, 1.0 g/L; MgSO<sub>4</sub>&#x000b7;7H<sub>2</sub>O, 0.5 g/L; agar, 15.0 g/L; water to 1 L [pH 7.2 to 7.4]) and incubation temperature of 28&#x000b0;C. Genomic DNA of YIM 121038 was isolated as described below and was used as a template to PCR amplify a 16S rRNA gene fragment using a previously described protocol (<xref rid="B25" ref-type="bibr">25</xref>). The resulting DNA fragment was sequenced, and the sequence was deposited in GenBank.</p></sec><sec id="s4-2"><title>Genome sequencing and analyses.</title><p>For genome sequencing, chromosomal DNA was used to generate a TruSeq PCR-free library that was sequenced on an Illumina MiSeq system in a 2&#x000d7; 300-nucleotide (nt) run. A total of 559.3 Mbp of sequence materials (52.4&#x000d7; coverage) was assembled using Newbler version 2.8 (Roche), resulting in 117 scaffolds containing 214 contigs. Subsequently, 400&#x02009;ng of genomic DNA was used to generate a second shotgun library for sequencing on the MinION system (Oxford Nanopore Technologies). Using the rapid barcoding kit (SQK-RBK004), a one-dimensional (1D) sequencing library was created and sequenced on an R9.5 flow cell in a 24-h run on the MinION sequencer. Base calling and sequence material conversion were performed using Albacore version 2.1.7 (Oxford Nanopore Technologies), yielding 11,928 reads with a total length of 166.6 Mbp (13,964-nt average read length, 15&#x000d7; coverage). The assembly was performed with Canu version 1.6 (<xref rid="B26" ref-type="bibr">26</xref>). After assembly, the resulting three contigs were polished with the short Illumina reads using Pilon <sc>(</sc><xref rid="B27" ref-type="bibr">27</xref>). The final assembly and polishing were done manually using Consed <sc>(</sc><xref rid="B28" ref-type="bibr">28</xref>) to assemble the two contigs making up the chromosome and to resolve polishing artifacts in repetitive regions. This resulted in two contigs representing the complete linear chromosome and the complete linear plasmid pSSP121038. Gene prediction and annotation were performed applying Prokka <sc>(</sc><xref rid="B29" ref-type="bibr">29</xref>).</p><p>Phylogenetic analyses of 16S rRNA gene sequence and protein sequences of CsbB and its homologues were performed with MEGA7 (<xref rid="B30" ref-type="bibr">30</xref>).</p></sec><sec id="s4-3"><title>Generation of recombinant bacterial strains, plasmids, and general growth conditions.</title><p>The genomic DNA from <italic toggle="yes">Streptomyces</italic> was isolated using the Wizard Genomic DNA purification kit (Promega, USA), as described previously (<xref rid="B31" ref-type="bibr">31</xref>). The culture was prepared by inoculation of 50&#x02009;mL of 3% tryptic soy broth (TSB) medium (Oxoid, United Kingdom) with 50 &#x003bc;L of fresh prepared spore suspension (20% [vol/vol] glycerol) and incubation in 250-mL baffled flasks at 28&#x000b0;C at 250&#x02009;rpm. All routine DNA standard techniques, cloning methods, and plasmid transformation into <named-content content-type="genus-species">Escherichia coli</named-content> were performed as described by Sambrook et al. (<xref rid="B32" ref-type="bibr">32</xref>). PCR amplifications were done with Q5 high-fidelity DNA polymerase (New England Biolabs) using oligonucleotides listed in <xref rid="tabS3" ref-type="supplementary-material">Table&#x000a0;S3</xref>A in the supplemental material. Plasmids and bacterial strains used or constructed during this study are represented in <xref rid="tabS3" ref-type="supplementary-material">Table&#x000a0;S3</xref>B.</p><supplementary-material position="float" id="tabS3" content-type="local-data"><object-id pub-id-type="doi">10.1128/mbio.01789-22.8</object-id><label>TABLE&#x000a0;S3</label><p>(A) Oligonucleotides used in this study. Italic indicates an endonuclease restriction enzyme site. (B) Plasmids and bacterial strains used in this work. Download <inline-supplementary-material id="tS3" xlink:href="mbio.01789-22-s0003.docx" content-type="local-data">Table&#x000a0;S3, DOCX file, 0.02 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2022 Schneider et al.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Schneider et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2022-08-30"/><license license-type="open-access"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="version-of-record">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material><p><named-content content-type="genus-species">Escherichia coli</named-content> strains were grown in Luria-Bertani (LB) broth or on LB agar supplemented with chloramphenicol (25&#x02009;&#x003bc;g mL<sup>&#x02212;1</sup>), apramycin (100&#x02009;&#x003bc;g mL<sup>&#x02212;1</sup>), and kanamycin (25&#x02009;&#x003bc;g mL<sup>&#x02212;1</sup>). XL1-Blue was used for general cloning, and ET12567(pUZ8002) was used for intergeneric conjugative transfer of plasmids to <italic toggle="yes">Streptomyces</italic>, as described previously (<xref rid="B33" ref-type="bibr">33</xref>).</p></sec><sec id="s4-4"><title>Identification, purification, and structure elucidation of new compounds.</title><p><italic toggle="yes">Streptomyces</italic> sp. strain YIM 121038 was cultured in 500&#x02009;mL TSB medium plus apramycin at 30&#x000b0;C for 4&#x02009;days on the shaker. The culture was centrifuged and the pellet was extracted with acetone. The extract was dried and separated by RP-HPLC (Phenomenex Luna 5-&#x003bc;m C<sub>18</sub>, 10 by&#x02009;250&#x02009;mm, 2.0&#x02009;mL/min, 220&#x02009;nm) with a gradient elution from 5% MeCN&#x02009;plus&#x02009;0.1% formic acid (FA) to 100% MeCN plus 0.1% FA. The fraction containing compound 1 was further separated by RP-HPLC (Phenomenex Luna 5-&#x003bc;m phenyl-hexyl, 10&#x02009;by&#x02009;250&#x02009;mm, 2.0&#x02009;mL/min, 200&#x02009;nm) with 30% MeCN plus&#x02009;0.1% FA to obtain desertomycin X (compound 1) (1.0&#x02009;mg). Fraction containing compound 2 was separated by RP-HPLC (Phenomenex Kinetex 5-&#x003bc;m C<sub>18</sub>, 10&#x02009;by&#x02009;250&#x02009;mm, 2.0&#x02009;mL/min, 200&#x02009;nm) with 27% MeCN&#x02009;plus&#x02009;0.1% FA to obtain desertomycin A (compound 2) (3.9&#x02009;mg).</p><p>LC-ESIMS was performed on a Thermo Scientific Q Exactive mass spectrometer coupled to a Dionex Ultimate 3000 ultraperformance liquid chromatography (UPLC) system. NMR spectra were recorded on a Bruker Avance III spectrometer equipped with a cold probe at 500&#x02009;MHz and 600&#x02009;MHz for <sup>1</sup>H NMR and 125&#x02009;MHz and 150&#x02009;MHz for <sup>13</sup>C NMR at 298 K. Chemical shifts were referenced to the solvent peaks at &#x003b4;H 2.50 and &#x003b4;C 39.51 for DMSO-<italic toggle="yes">d</italic><sub>6</sub> and &#x003b4;H 3.31 and &#x003b4;C 49.15 for methanol-<italic toggle="yes">d</italic><sub>4</sub>. NMR data are presented in <xref rid="tabS4" ref-type="supplementary-material">Table&#x000a0;S4</xref>A and B.</p><supplementary-material position="float" id="tabS4" content-type="local-data"><object-id pub-id-type="doi">10.1128/mbio.01789-22.9</object-id><label>TABLE&#x000a0;S4</label><p>(A) NMR data of desertomycin X (compound 1); (B) NMR data of desertomycin A (compound 2). Download <inline-supplementary-material id="tS4" xlink:href="mbio.01789-22-s0004.docx" content-type="local-data">Table&#x000a0;S4, DOCX file, 0.02 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2022 Schneider et al.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Schneider et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2022-08-30"/><license license-type="open-access"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="version-of-record">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material><p>To analyze the time-dependent production of desertomycin A and desertomycin X, <italic toggle="yes">Streptomyces</italic> sp. strain YIM 121038 was cultured in 20&#x02009;mL TSB medium supplied with apramycin at 30&#x000b0;C for 6&#x02009;days on the shaker. Two milliliters of culture was sampled daily with further separation of supernatant and pellet by centrifugation and freeze drying. Next, the supernatant was extracted with methanol and the pellet with 80% acetone.</p></sec><sec id="s4-5"><title>Antimicrobial activity testing.</title><p>Testing of antimicrobial activities of desertomycin A and X was done by disk diffusion assay using <named-content content-type="genus-species">Bacillus subtilis</named-content> 164, <named-content content-type="genus-species">Escherichia coli</named-content> DH5a, and <named-content content-type="genus-species">Saccharomyces cerevisiae</named-content> BY4742 as test organisms. Desertomycins were dissolved in DMSO to a stock solution of 8&#x02009;mg/mL and tested in triplicate at final assay concentrations from 128 to 0.25&#x02009;&#x003bc;g/mL. <italic toggle="yes">In vitro</italic> susceptibility for desertomycin A was determined at Medina Foundation (Granada, Spain) by the broth microdilution method following the Clinical and Laboratory Standards Institute protocol (<xref rid="B34" ref-type="bibr">34</xref>) using bacterial strains from the company&#x02019;s strain collection (<xref rid="tabS4" ref-type="supplementary-material">Table&#x000a0;S4</xref>).</p></sec><sec id="s4-6"><title>Construction of the CsbC expression vectors.</title><p>Expression of codon-optimized gene <italic toggle="yes">csbC</italic> was carried out using the pET-30a(+) vector (Novagen). The synthetic <italic toggle="yes">csbC</italic> gene encoded the protein with 6&#x000d7;His tag on its N terminus, and was cloned into the pET30a(+) vector as a NdeI-BamHI fragment, yielding the pET-CsbC-S vector. For the experiments aimed at verifying enzyme activity <italic toggle="yes">in vivo</italic>, the vector pET-CsbC-S was modified by replacement of the gene Kan<sup>r</sup> gene by the Amp<sup>r</sup> gene. For this purpose, the Amp<sup>r</sup> gene cassette (1,150&#x02009;bp) was amplified from the pGEM-3Zf(+) vector with the primer set pGEM_Amp_fwd/pGEM_Amp_rev (supplemental material), and the PCR product was introduced into the 5.3-kb SmaI/PsiI fragment of the vector pET-CsbC-S and 4.7-kb SmaI/PsiI fragment of the vector pET30a(+) via Gibson assembly, yielding plasmids pA_CsbC-S and pA (negative control in assays). To prove the activity of CsbC <italic toggle="yes">in vivo Streptomyces</italic> cells, the pUWL_CsbCwt vector was generated; its construction was based on ligation of the amplified native gene <italic toggle="yes">csbC</italic> from YIM 121038 genomic DNA (gDNA) (designated below as <italic toggle="yes">csbCwt</italic>) and the pUWLoriT vector, over restriction enzymes MfeI/HindIII and EcoRI/HindIII, respectively.</p></sec><sec id="s4-7"><title>Heterologous expression of recombinant CsbC.</title><p>To determine the activity of the CsbC enzyme <italic toggle="yes">in vitro</italic>, it was expressed in <named-content content-type="genus-species">Escherichia coli</named-content> BL21(DE3) (Invitrogen, Carlsbad, CA, USA) cells harboring pET-CsbC vector. After overnight incubation at 37&#x000b0;C with kanamycin, a 5-mL overnight culture was used to inoculate 200&#x02009;mL triconcentrated LB medium supplemented with kanamycin. The cultivation was carried out at 37&#x000b0;C. To initiate overexpression, the culture was induced with 0.5&#x02009;mM final concentration of isopropyl-&#x003b2;-<sc>d</sc>-thiogalactopyranoside (IPTG) when it reached an optical density at 600 nm (OD<sub>600</sub>) of 1. After induction, the incubation was continued for 2 h at 25&#x000b0;C and overnight at 15&#x000b0;C at 220&#x02009;rpm. Cells were harvested by centrifugation (15&#x02009;min at 4,000&#x02009;&#x000d7;&#x02009;rpm at 4&#x000b0;C).</p><p>The cell pellet was resuspended in 10&#x02009;mL lysis buffer (50&#x02009;mM potassium phosphate buffer [pH 8], 300&#x02009;mM NaCl, 10&#x02009;mM imidazole, 1&#x02009;mM dithiothreitol [DTT], 100&#x02009;&#x003bc;g/mL lysozyme), and the cells were disrupted using a Bioruptor Plus (amplitude, 30%; cycle 3) for 10&#x02009;min. The sonicated samples were centrifuged for 30&#x02009;min at 10,000&#x02009;rpm at 4&#x000b0;C, and the supernatant was filtrated through a 2-&#x003bc;m-pore filter to remove cell debris. CsbC with a fused 6&#x000d7;His tag was purified via Ni-nitrilotriacetic acid (NTA) affinity chromatography following the manufacturer&#x02019;s protocol (Qiagen), with the following exceptions for the buffers: washing buffer (50&#x02009;mM potassium phosphate buffer [pH 8], 300&#x02009;mM NaCl, 20&#x02009;mM imidazole, 1&#x02009;mM DTT), elution buffer (50&#x02009;mM potassium phosphate buffer [pH 8]), and dialysis buffer (50&#x02009;mM Tris/HCl [pH 8], 50&#x02009;mM NaCl). The purity of recombinant CsbC and its concentration were determined by SDS-PAGE and the Bradford assay, respectively.</p></sec><sec id="s4-8"><title>Assays for CsbC activity <italic toggle="yes">in vitro</italic>.</title><p>The assay for CsbC activity was carried out in 50&#x02009;mM Tris-HCl (pH 8) containing 25&#x02009;mM succinyl-CoA sodium salt (Sigma-Aldrich) and various compounds as acyl group acceptors. The following acceptor compounds were used: 4&#x02009;mM putrescine, 4&#x02009;mM ornithine, 0.4&#x02009;mM desertomycin A, ethionamide, colistin, vancomycin, gentamicin, daptomycin, tetracycline, kanamycin, ampicillin, and 0.2&#x02009;mM trimethoprim. Activity of CsbC with substrates kanamycin, ampicillin, and acetyl-CoA was also investigated. The total reaction mixture of 100 &#x003bc;L was incubated 2 h at 30&#x000b0;C, and the reaction was terminated by addition of 0.5 &#x003bc;L formic acid. Negative-control samples were prepared in the same way, except that formic acid was added to the mixture before substrate to deactivate CsbC. After the reaction was terminated, 50 &#x003bc;L of reaction mixture was applied directly onto the disc for bioassays, and the remaining 50 &#x003bc;L was analyzed with LC-MS/MS.</p></sec><sec id="s4-9"><title>Generation and analysis of enzyme kinetics data.</title><p>To study the kinetics of CsbC, a 50-&#x003bc;L reaction mixture was prepared, containing 50&#x02009;mM Tris-HCl, 25&#x02009;mM succinyl-CoA, 2&#x02009;mg/mL CsbC, and various ampicillin (Amp) concentrations (0 to 8.1&#x02009;mM). Reaction mixtures were incubated at 30&#x000b0;C and terminated at different time points (0, 5, 10, 30, 60, 90, and 120&#x02009;min) by addition of 0.5% formic acid. Denatured protein was removed by centrifugation (13,000&#x02009;rpm, 15&#x02009;min), and formation of succinylated ampicillin (Amp-S) was monitored by HPLC (with the same column and conditions as for LC-MS/MS analysis) by injection of a 5-&#x003bc;L sample. The peak area for Amp-S at ca. 18&#x02009;min and 190&#x02009;nm (Area<sub>unknown</sub>) was identified with LabSolutions version 5.97 software (Shimadzu Corporations). As a standard concentration (<italic toggle="yes">C</italic><sub>known</sub>), the sample with 0.2&#x02009;mmol Amp was used. In this reaction, according to the HPLC chromatogram, all Amp was succinylated after 30&#x02009;min of incubation. Thus, the measured area in HPLC at 190&#x02009;nm (Area<sub>known</sub>) and known standard concentrations (0.2&#x02009;mmol) were used in the following equation to determine <italic toggle="yes">C</italic><sub>unknown</sub>: <italic toggle="yes">C</italic><sub>unknown</sub> = (Area<sub>unknown</sub>/Area<sub>known</sub>) &#x000d7; <italic toggle="yes">C</italic><sub>known</sub>.</p></sec><sec id="s4-10"><title>LC-MS analyses.</title><p>LC-MS/MS analyses of the reaction mixtures were performed on a Vanquish Horizon UHPLC system (Thermo Fisher Scientific) coupled to the ESI source of an LTQ Orbitrap Velos mass spectrometer (Thermo Fisher Scientific). Separation was carried out on an Acclaim 120 C<sub>18</sub> column (2.1&#x02009;by&#x02009;150 mm, 3&#x02009;&#x003bc;m) (Thermo Fisher Scientific) using water and acetonitrile, both modified with 0.1% formic acid, as mobile phases A and B, respectively. Depending on the polarity of the substrate, the sample components were separated and eluted with either of the following two gradient programs: (i) a linear gradient from 5% to 95% B in 45&#x02009;min, followed by an isocratic column cleaning (9.5&#x02009;min at 95% B) and reequilibration step (10&#x02009;min at 5% B); or (ii) a gradient starting with an isocratic step at 3% B for 1&#x02009;min, followed by a linear gradient from 3% to 30% B in 9&#x02009;min, an increase to 95% B in 0.5&#x02009;min, and finally an isocratic column cleaning (5&#x02009;min at 95% B) and reequilibration step (9&#x02009;min at 3% B). The flow rates were 0.45 and 0.50&#x02009;mL/min, respectively, and the column oven temperature was set to 25&#x000b0;C. High-resolution ESI-MS (HR-ESIMS) spectra were recorded in positive-ion mode with an FT resolution of 60.000. High- or low-resolution ESIMS/MS spectra of the three most intense precursor ions in each MS<sup>1</sup> spectrum were obtained in automated materials-dependent acquisition mode using helium as the collision gas and the following settings: activation type, CID; isolation width, &#x00394;<italic toggle="yes">m</italic>/<italic toggle="yes">z&#x02009;</italic>=<italic toggle="yes">&#x02009;</italic>3; normalized collision energy, 35.0; activation Q, 0.250; and activation time, 30&#x02009;ms.</p><p>LC-MS/MS data for the cell pellet and supernatant extracts of the <italic toggle="yes">Streptomyces</italic> sp. strain YIM 121038 cultures were obtained on a Vanquish Horizon UHPLC system coupled to a timsTOF fleX mass spectrometer (Bruker Daltonics) under similar conditions to those described above.</p></sec><sec id="s4-11"><title>CsbC activity <italic toggle="yes">in vivo</italic>.</title><p>To test an <italic toggle="yes">in vivo</italic> activity of CsbC, the experiments were carried with <named-content content-type="genus-species">E. coli</named-content> BL21(DE3) and <named-content content-type="genus-species">S. lividans</named-content> TK24 strains. Single colonies of <named-content content-type="genus-species">E. coli</named-content> BL21 strains carrying <italic toggle="yes">csbC</italic>-expressing vectors pET-CsbC or pA-CsbC and control vector pET30a(+) or pA were inoculated in LB containing Kan for pET constructs or Amp for pA constructs and incubated for 18 h at 37&#x000b0;C. One&#x02009;milliliter of overnight cultures was added into the 250&#x02009;mL LB supplemented with Kan/Amp and incubated at 37&#x000b0;C up to an OD<sub>600</sub> of 0.25. Next, samples were divided, and some were induced with 0.1&#x02009;mM IPTG and incubated at 20&#x000b0;C for 1 h (pET constructs) or at 30&#x000b0;C for 30&#x02009;min (pA vectors). After induction, some samples containing pA vectors were supplemented with 5&#x02009;&#x003bc;g/mL Kan. After 24 h of incubation, 2&#x02009;mL of the cultures was harvested, the obtained cell pellet was resuspended in 1&#x02009;mL lysis buffer, and the cells were disrupted by sonication. The production of CsbC was determined by Western blotting with 15 &#x003bc;L filtered extract using an antibody specific for the 6&#x000d7;His tag.</p><p>After induction, different concentrations of Amp (0 to 50&#x02009;&#x003bc;g/mL) were added to the cultures harboring pET30a(+) and pET-CsbC vectors with subsequent incubation for 18 h at 20&#x000b0;C and determination of the final OD<sub>600</sub>.</p><p>Fifty microliters each of spore suspension of <named-content content-type="genus-species">S. lividans</named-content>/pUWL-<italic toggle="yes">csbC</italic> and <named-content content-type="genus-species">S. lividans</named-content>/pUWLoriT strains was inoculated in YEME medium (<xref rid="B35" ref-type="bibr">35</xref>) supplemented with 30&#x02009;&#x003bc;g/mL thiostrepton and kanamycin (0, 1, 2.5, 5, and 7&#x02009;&#x003bc;g/mL) and incubated for 3&#x02009;days at 28&#x000b0;C at 220&#x02009;rpm. In parallel, 50 &#x003bc;L of spore suspension were plated on SFM agar plates with the same antibiotic concentrations as for liquid YEME medium and incubated at 28&#x000b0;C.</p></sec><sec id="s4-12"><title>Data availability.</title><p>This genome project has been deposited in DDBJ/ENA/GenBank under accession no. <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/CP030771.1" ext-link-type="uri">CP030771.1</ext-link> (chromosome) and <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/CP030772.1" ext-link-type="uri">CP030772.1</ext-link> (plasmid pSSP121038). The sequence of the 16S rRNA gene fragment of genomic DNA from YIM 121038 has been deposited in GenBank under accession no. <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/MH429786" ext-link-type="uri">MH429786</ext-link>.</p></sec></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>We thank Anna Fabisikova for assistance with LC-MS data acquisition and acknowledge support by the Mass Spectrometry Centre of the Faculty of Chemistry, University of Vienna.</p><p>This study was supported by the University of Vienna, Austrian Science fund (grant P 32823), University of Bielefeld, and Yunnan University.</p></ack><ref-list><title>REFERENCES</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Baltz</surname>
<given-names>RH</given-names></string-name></person-group>. <year>2021</year>. <article-title>Genome mining for drug discovery: progress at the front end</article-title>. <source>J Ind Microbiol Biotechnol</source>
<volume>48</volume>:<fpage>kuab044</fpage>. doi:<pub-id pub-id-type="doi">10.1093/jimb/kuab044</pub-id>.<pub-id pub-id-type="pmid">34279640</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Al-Shaibani</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Radin Mohamed</surname>
<given-names>RMS</given-names></string-name>, <string-name><surname>Sidik</surname>
<given-names>NM</given-names></string-name>, <string-name><surname>Enshasy</surname>
<given-names>HAE</given-names></string-name>, <string-name><surname>Al-Gheethi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Noman</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Al-Mekhlafi</surname>
<given-names>NA</given-names></string-name>, <string-name><surname>Zin</surname>
<given-names>NM</given-names></string-name></person-group>. <year>2021</year>. <article-title>Biodiversity of secondary metabolites compounds isolated from phylum Actinobacteria and its therapeutic applications</article-title>. <source>Molecules</source>
<volume>26</volume>:<fpage>4504</fpage>. doi:<pub-id pub-id-type="doi">10.3390/molecules26154504</pub-id>.<pub-id pub-id-type="pmid">34361657</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cundliffe</surname>
<given-names>E</given-names></string-name></person-group>. <year>1989</year>. <article-title>How antibiotic-producing organisms avoid suicide</article-title>. <source>Annu Rev Microbiol</source>
<volume>43</volume>:<fpage>207</fpage>&#x02013;<lpage>233</lpage>. <comment>(1989)</comment>. doi:<pub-id pub-id-type="doi">10.1146/annurev.mi.43.100189.001231</pub-id>.<pub-id pub-id-type="pmid">2679354</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Graham</surname>
<given-names>MY</given-names></string-name>, <string-name><surname>Weisblum</surname>
<given-names>B</given-names></string-name></person-group>. <year>1979</year>. <article-title>23S ribosomal ribonucleic acid of macrolide-producing streptomycetes contains methylated adenine</article-title>. <source>J Bacteriol</source>
<volume>137</volume>:<fpage>1464</fpage>&#x02013;<lpage>1467</lpage>. doi:<pub-id pub-id-type="doi">10.1128/jb.137.3.1464-1467.1979</pub-id>.<pub-id pub-id-type="pmid">438126</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ohnuki</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Katoh</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Imanaka</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Aiba</surname>
<given-names>S</given-names></string-name></person-group>. <year>1985</year>. <article-title>Molecular cloning of tetracycline resistance genes from <italic toggle="yes">Streptomyces rimosus</italic> in <italic toggle="yes">Streptomyces griseus</italic> and characterization of the cloned genes</article-title>. <source>J Bacteriol</source>
<volume>161</volume>:<fpage>1010</fpage>&#x02013;<lpage>1016</lpage>. doi:<pub-id pub-id-type="doi">10.1128/jb.161.3.1010-1016.1985</pub-id>.<pub-id pub-id-type="pmid">2982781</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nguyen</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Starosta</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Arenz</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Sohmen</surname>
<given-names>D</given-names></string-name>, <string-name><surname>D&#x000f6;nh&#x000f6;fer</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Wilson</surname>
<given-names>DN</given-names></string-name></person-group>. <year>2014</year>. <article-title>Tetracycline antibiotics and resistance mechanisms</article-title>. <source>Biol Chem</source>
<volume>395</volume>:<fpage>559</fpage>&#x02013;<lpage>575</lpage>. doi:<pub-id pub-id-type="doi">10.1515/hsz-2013-0292</pub-id>.<pub-id pub-id-type="pmid">24497223</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Favrot</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Blanchard</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Vergnolle</surname>
<given-names>O</given-names></string-name></person-group>. <year>2016</year>. <article-title>Bacterial GCN5-related N-acetyltransferases: from resistance to regulation</article-title>. <source>Biochemistry</source>
<volume>55</volume>:<fpage>989</fpage>&#x02013;<lpage>1002</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acs.biochem.5b01269</pub-id>.<pub-id pub-id-type="pmid">26818562</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Farazi</surname>
<given-names>TA</given-names></string-name>, <string-name><surname>Waksman</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Gordon</surname>
<given-names>JI</given-names></string-name></person-group>. <year>2001</year>. <article-title>Structures of <italic toggle="yes">Saccharomyces cerevisiae N</italic>-myristoyltransferase with bound myristoyl CoA and peptide provide insights about substrate recognition and catalysis</article-title>. <source>Biochemistry</source>
<volume>40</volume>:<fpage>6335</fpage>&#x02013;<lpage>6343</lpage>. doi:<pub-id pub-id-type="doi">10.1021/bi0101401</pub-id>.<pub-id pub-id-type="pmid">11371195</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vetting</surname>
<given-names>MW</given-names></string-name>, <string-name><surname>Errey</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Blanchard</surname>
<given-names>JS</given-names></string-name></person-group>. <year>2008</year>. <article-title>Rv0802c from <italic toggle="yes">Mycobacterium tuberculosis</italic>: the first structure of a succinyltransferase with the GNAT fold</article-title>. <source>Acta Crystallogr Sect F Struct Biol Cryst Commun</source>
<volume>64</volume>:<fpage>978</fpage>&#x02013;<lpage>985</lpage>. doi:<pub-id pub-id-type="doi">10.1107/S1744309108031679</pub-id>.</mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Anand</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Santoshi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Singh</surname>
<given-names>PR</given-names></string-name>, <string-name><surname>Nagaraja</surname>
<given-names>V</given-names></string-name></person-group>. <year>2021</year>. <article-title>Rv0802c is an acyltransferase that succinylates and acetylates <italic toggle="yes">Mycobacterium tuberculosis</italic> nucleoid-associated protein HU</article-title>. <source>Microbiology (Reading)</source>. doi:<pub-id pub-id-type="doi">10.1099/mic.0.001058</pub-id>.</mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Davies</surname>
<given-names>J</given-names></string-name></person-group>. <year>1994</year>. <article-title>Inactivation of antibiotics and the dissemination of resistance genes</article-title>. <source>Science</source>
<volume>264</volume>:<fpage>375</fpage>&#x02013;<lpage>382</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.8153624</pub-id>.<pub-id pub-id-type="pmid">8153624</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Matsuhashi</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Murakami</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Nojiri</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Toyama</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Anzai</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Nagaoka</surname>
<given-names>K</given-names></string-name></person-group>. <year>1985</year>. <article-title>Mechanisms of aminoglycosideresistance of Streptomyces harboring resistant genes obtained from antibiotic-producers</article-title>. <source>J Antibiot (Tokyo)</source>
<volume>38</volume>:<fpage>279</fpage>&#x02013;<lpage>282</lpage>. doi:<pub-id pub-id-type="doi">10.7164/antibiotics.38.279</pub-id>.<pub-id pub-id-type="pmid">3838980</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kharel</surname>
<given-names>MK</given-names></string-name>, <string-name><surname>Subba</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Basnet</surname>
<given-names>DB</given-names></string-name>, <string-name><surname>Woo</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>HC</given-names></string-name>, <string-name><surname>Liou</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Sohng</surname>
<given-names>JK</given-names></string-name></person-group>. <year>2004</year>. <article-title>A gene cluster for biosynthesis of kanamycin from <italic toggle="yes">Streptomyces kanamyceticus</italic>: comparison with gentamicin biosynthetic gene cluster</article-title>. <source>Arch Biochem Biophys</source>
<volume>429</volume>:<fpage>204</fpage>&#x02013;<lpage>214</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.abb.2004.06.009</pub-id>.<pub-id pub-id-type="pmid">15313224</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Blin</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Shaw</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Kloosterman</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Charlop-Powers</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>van Wezel</surname>
<given-names>GP</given-names></string-name>, <string-name><surname>Medema</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Weber</surname>
<given-names>T</given-names></string-name></person-group>. <year>2021</year>. <article-title>antiSMASH 6.0: improving cluster detection and comparison capabilities</article-title>. <source>Nucleic Acids Res</source>
<volume>49</volume>:<fpage>W29</fpage>&#x02013;<lpage>W35</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkab335</pub-id>.<pub-id pub-id-type="pmid">33978755</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bax</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Aszalos</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Dinya</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Sudo</surname>
<given-names>K</given-names></string-name></person-group>. <year>1986</year>. <article-title>Structure elucidation of the antibiotic desertomycin through the use of new two-dimensional NMR techniques</article-title>. <source>J Am Chem Soc</source>
<volume>108</volume>:<fpage>8056</fpage>&#x02013;<lpage>8063</lpage>. doi:<pub-id pub-id-type="doi">10.1021/ja00285a029</pub-id>.</mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hashimoto</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Kozone</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Hashimoto</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Suenaga</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Fujie</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Satoh</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Ikeda</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Shin-ya</surname>
<given-names>K</given-names></string-name></person-group>. <year>2020</year>. <article-title>Identification, cloning and heterologous expression of biosynthetic gene cluster for desertomycin</article-title>. <source>J Antibiot</source>
<volume>73</volume>:<fpage>650</fpage>&#x02013;<lpage>654</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41429-020-0319-0</pub-id>.</mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Card</surname>
<given-names>GL</given-names></string-name>, <string-name><surname>Peterson</surname>
<given-names>NA</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Rupp</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Schick</surname>
<given-names>BM</given-names></string-name>, <string-name><surname>Baker</surname>
<given-names>EN</given-names></string-name></person-group>. <year>2005</year>. <article-title>The crystal structure of Rv1347c, a putative antibiotic resistance protein from <italic toggle="yes">Mycobacterium tuberculosis</italic>, reveals a GCN5-related fold and suggests an alternative function in siderophore biosynthesis</article-title>. <source>J Biol Chem</source>
<volume>280</volume>:<fpage>13978</fpage>&#x02013;<lpage>13986</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M413904200</pub-id>.<pub-id pub-id-type="pmid">15695811</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lorenzo</surname>
<given-names>VD</given-names></string-name>, <string-name><surname>Neilands</surname>
<given-names>JB</given-names></string-name></person-group>. <year>1986</year>. <article-title>Characterization of <italic toggle="yes">iucA</italic> and <italic toggle="yes">iucC</italic> genes of the aerobactin system of plasmid Co1V-K30 in <italic toggle="yes">Escherichia coli</italic></article-title>. <source>J Bacteriol</source>
<volume>167</volume>:<fpage>350</fpage>&#x02013;<lpage>355</lpage>. doi:<pub-id pub-id-type="doi">10.1128/jb.167.1.350-355.1986</pub-id>.<pub-id pub-id-type="pmid">3087960</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Burrell</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Hanfrey</surname>
<given-names>CC</given-names></string-name>, <string-name><surname>Kinch</surname>
<given-names>LN</given-names></string-name>, <string-name><surname>Elliott</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Michael</surname>
<given-names>AJ</given-names></string-name></person-group>. <year>2012</year>. <article-title>Evolution of a novel lysine decarboxylase in siderophore biosynthesis: a novel lysine decarboxylase</article-title>. <source>Mol Microbiol</source>
<volume>86</volume>:<fpage>485</fpage>&#x02013;<lpage>499</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2958.2012.08208.x</pub-id>.<pub-id pub-id-type="pmid">22906379</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Waglechner</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Culp</surname>
<given-names>EJ</given-names></string-name>, <string-name><surname>Wright</surname>
<given-names>GD</given-names></string-name></person-group>. <day>17</day>
<month>March</month>
<year>2021</year>, posting date. <article-title>Ancient antibiotics, ancient resistance</article-title>. <source>EcoSal Plus</source>
<comment>2021</comment>. doi:<pub-id pub-id-type="doi">10.1128/ecosalplus.ESP-0027-2020</pub-id>.</mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pinheiro</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Petrov</surname>
<given-names>DP</given-names></string-name>, <string-name><surname>Guo</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Martins</surname>
<given-names>GB</given-names></string-name>, <string-name><surname>Bramkamp</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Jung</surname>
<given-names>K</given-names></string-name></person-group>. <year>2021</year>. <article-title>Elongation factor P is required for EIIGlc translation in <italic toggle="yes">Corynebacterium glutamicum</italic> due to an essential polyproline motif</article-title>. <source>Mol Microbiol</source>
<volume>115</volume>:<fpage>320</fpage>&#x02013;<lpage>331</lpage>. doi:<pub-id pub-id-type="doi">10.1111/mmi.14618</pub-id>.<pub-id pub-id-type="pmid">33012080</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Miroux</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Walker</surname>
<given-names>JE</given-names></string-name></person-group>. <year>1996</year>. <article-title>Over-production of proteins in <italic toggle="yes">Escherichia coli</italic>: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels</article-title>. <source>J Mol Biol</source>
<volume>260</volume>:<fpage>289</fpage>&#x02013;<lpage>298</lpage>. doi:<pub-id pub-id-type="doi">10.1006/jmbi.1996.0399</pub-id>.<pub-id pub-id-type="pmid">8757792</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jackowski</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Rock</surname>
<given-names>CO</given-names></string-name></person-group>. <year>1986</year>. <article-title>Consequences of reduced intracellular coenzyme A content in <italic toggle="yes">Escherichia coli</italic></article-title>. <source>J Bacteriol</source>
<volume>166</volume>:<fpage>866</fpage>&#x02013;<lpage>871</lpage>. doi:<pub-id pub-id-type="doi">10.1128/jb.166.3.866-871.1986</pub-id>.<pub-id pub-id-type="pmid">3519582</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Traxler</surname>
<given-names>MF</given-names></string-name>, <string-name><surname>Kolter</surname>
<given-names>R</given-names></string-name></person-group>. <year>2015</year>. <article-title>Natural products in soil microbe interactions and evolution</article-title>. <source>Nat Prod Rep</source>
<volume>32</volume>:<fpage>956</fpage>&#x02013;<lpage>970</lpage>. doi:<pub-id pub-id-type="doi">10.1039/c5np00013k</pub-id>.<pub-id pub-id-type="pmid">26000872</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bredholdt</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Galatenko</surname>
<given-names>OA</given-names></string-name>, <string-name><surname>Engelhardt</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Fjaervik</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Terekhova</surname>
<given-names>LP</given-names></string-name>, <string-name><surname>Zotchev</surname>
<given-names>SB</given-names></string-name></person-group>. <year>2007</year>. <article-title>Rare actinomycete bacteria from the shallow water sediments of the Trondheim fjord, Norway: isolation, diversity and biological activity</article-title>. <source>Environ Microbiol</source>
<volume>9</volume>:<fpage>2756</fpage>&#x02013;<lpage>2764</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1462-2920.2007.01387.x</pub-id>.<pub-id pub-id-type="pmid">17922759</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Koren</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Walenz</surname>
<given-names>BP</given-names></string-name>, <string-name><surname>Berlin</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Miller</surname>
<given-names>JR</given-names></string-name>, <string-name><surname>Bergman</surname>
<given-names>NH</given-names></string-name>, <string-name><surname>Phillippy</surname>
<given-names>AM</given-names></string-name></person-group>. <year>2017</year>. <article-title>Canu: scalable and accurate long-read assembly via adaptive <italic toggle="yes">k</italic>-mer weighting and repeat separation</article-title>. <source>Genome Res</source>
<volume>27</volume>:<fpage>722</fpage>&#x02013;<lpage>736</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gr.215087.116</pub-id>.<pub-id pub-id-type="pmid">28298431</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Walker</surname>
<given-names>BJ</given-names></string-name>, <string-name><surname>Abeel</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Shea</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Priest</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Abouelliel</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Sakthikumar</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Cuomo</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Zeng</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Wortman</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Young</surname>
<given-names>SK</given-names></string-name>, <string-name><surname>Earl</surname>
<given-names>AM</given-names></string-name></person-group>. <year>2014</year>. <article-title>Pilon: an integrated tool for comprehensive microbial variant detection and genome assembly improvement</article-title>. <source>PLoS One</source>
<volume>9</volume>:<elocation-id>e112963</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0112963</pub-id>.<pub-id pub-id-type="pmid">25409509</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gordon</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Green</surname>
<given-names>P</given-names></string-name></person-group>. <year>2013</year>. <article-title>Consed: a graphical editor for next-generation sequencing</article-title>. <source>Bioinformatics</source>
<volume>29</volume>:<fpage>2936</fpage>&#x02013;<lpage>2937</lpage>. doi:<pub-id pub-id-type="doi">10.1093/bioinformatics/btt515</pub-id>.<pub-id pub-id-type="pmid">23995391</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Seemann</surname>
<given-names>T</given-names></string-name></person-group>. <year>2014</year>. <article-title>Prokka: rapid prokaryotic genome annotation</article-title>. <source>Bioinformatics</source>
<volume>30</volume>:<fpage>2068</fpage>&#x02013;<lpage>2069</lpage>. doi:<pub-id pub-id-type="doi">10.1093/bioinformatics/btu153</pub-id>.<pub-id pub-id-type="pmid">24642063</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kumar</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Stecher</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Knyaz</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Tamura</surname>
<given-names>K</given-names></string-name></person-group>. <year>2018</year>. <article-title>MEGA X: molecular evolutionary genetics analysis across computing platforms</article-title>. <source>Mol Biol Evol</source>
<volume>35</volume>:<fpage>1547</fpage>&#x02013;<lpage>1549</lpage>. doi:<pub-id pub-id-type="doi">10.1093/molbev/msy096</pub-id>.<pub-id pub-id-type="pmid">29722887</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schaffert</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Albersmeier</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Winkler</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kalinowski</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zotchev</surname>
<given-names>SB</given-names></string-name>, <string-name><surname>R&#x000fc;ckert</surname>
<given-names>C</given-names></string-name></person-group>. <year>2016</year>. <article-title>Complete genome sequence of the actinomycete <italic toggle="yes">Actinoalloteichus hymeniacidonis</italic> type strain HPA 177T isolated from a marine sponge</article-title>. <source>Stand Genomic Sci</source>
<volume>11</volume>:<fpage>91</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s40793-016-0213-3</pub-id>.<pub-id pub-id-type="pmid">28031775</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Sambrook</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Fritsch</surname>
<given-names>EF</given-names></string-name>, <string-name><surname>Maniatis</surname>
<given-names>T</given-names></string-name></person-group>. <year>1989</year>. <source>Molecular cloning: a laboratory manual</source>, <edition>2nd ed</edition>. <publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>, <publisher-loc>Cold Spring Harbor, NY</publisher-loc>.</mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Flett</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Mersinias</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>CP</given-names></string-name></person-group>. <year>1997</year>. <article-title>High efficiency intergeneric conjugal transfer of plasmid DNA from <italic toggle="yes">Escherichia coli</italic> to methyl DNA-restricting streptomycetes</article-title>. <source>FEMS Microbiol Lett</source>
<volume>155</volume>:<fpage>223</fpage>&#x02013;<lpage>229</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1574-6968.1997.tb13882.x</pub-id>.<pub-id pub-id-type="pmid">9351205</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="book"><collab>Clinical and Laboratory Standards Institute</collab>. <year>2012</year>. <source>Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. M07-A9. Approved standard</source><edition>, 9th ed</edition>, <volume>vol 32</volume>. <publisher-name>Clinical and Laboratory Standards Institute</publisher-name>, <publisher-name>Wayne, PA</publisher-name>.</mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Hopwood</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Bibb</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Chater</surname>
<given-names>KF</given-names></string-name>, <string-name><surname>Kieser</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Bruton</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Kieser</surname>
<given-names>HM</given-names></string-name>, <string-name><surname>Lydiate</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>CP</given-names></string-name>, <string-name><surname>Ward</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Schrempf</surname>
<given-names>H</given-names></string-name></person-group>. <year>1985</year>. <source>Genetic manipulation of <italic toggle="yes">Streptomyces</italic>: a laboratory manual</source>. <publisher-name>John Innes Foundation</publisher-name>, <publisher-loc>Norwich, United Kingdom</publisher-loc>.</mixed-citation></ref></ref-list></back></article>